Safety alerts

Drug lookup, recalls and shortages

Look up any drug for its FDA label, shortage status and recalls. Below: the recalls that matter most right now, every recall of the last 90 days and every drug in shortage.

New recall alerts

From the last 30 days, often days or weeks before they reach the FDA’s weekly records: the FDA’s own device recall alerts, companies’ recall announcements (drugs, devices, supplements, and foods contaminated with germs or lead), and the USDA’s meat and poultry alerts

Recalls to know about

From the FDA’s recall records, with its newest postings as of Oct. 4 at 3:28 PM CT. Ranked by seriousness, how widely the drug is used, reach and recency

  • Sept. 23, 2026

    Drug recall, ongoing

    Thyroid

    Vitruvias Therapeutics, sold nationwide

    Vitruvias recalled 30 mg thyroid tablets, 100-count bottles, because testing found more active ingredient than the label states. Lot 504950, expiring 09/30/2026, was sold nationwide. 1955 bottles were recalled.

    FDA reason: Superpotent Drug

    Class I: could cause serious harm or death

    In the news: 43 news outlets covered this recall in the last two weeks.

    About 1.2 million people in the US are prescribed thyroid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Chlorthalidone

    Inventia Healthcare Limited, sold nationwide

    Inventia recalled chlorthalidone 25 mg tablets, 100 per bottle, because they did not dissolve as required, so the body may absorb less drug than intended. Batch RISA24002, expiring 04/2027, was sold nationwide. 13567 bottles were recalled.

    FDA reason: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    In the news: 48 news outlets covered this recall in the last two weeks.

    About 1.3 million people in the US are prescribed chlorthalidone each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Cyanocobalamin and Trace Elements Injection 4 and 7 more (12 products)

    American Regent, sold nationwide

    American Regent recalled cyanocobalamin 10,000 mcg/10 mL injection, Multrys 1 mL vials, acetylcysteine 20% 4 mL vials and papaverine 60 mg/2 mL injection vials because unwanted particles were found. Lots 25082, 25163 and other lots, expiring 9/30/2026 to 8/31/2027, went nationwide in the U.S.

    FDA reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

    Class I: could cause serious harm or death

    About 1.8 million people in the US are prescribed cyanocobalamin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Levothyroxine Sodium (12 products)

    Accord Healthcare, sold nationwide

    Levothyroxine Sodium Tablets, USP, 200 mcg in 90- and 1000-count bottles and 50, 125 and 25 mcg in 1000-count bottles, were recalled because testing found less active ingredient than labeled. Lots D2402430 and D2402431 and other lots, expiring from 08/31/2026 to 01/31/2027, were distributed nationwide.

    FDA reason: Subpotent Drug

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride

    B Braun Medical, sold nationwide

    B. Braun Lactated Ringer's Injection USP, 1000 mL EXCEL container, was recalled because particles that do not belong in the product were found. Lot J4H077, expiring 30NOV2026, was distributed nationwide. 23,688 bags were recalled.

    FDA reason: Presence of Particulate matter.

    Class I: could cause serious harm or death

    About 4.1 million people in the US are prescribed potassium chloride each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Semaglutide (11 products)

    Apollo Care, sold nationwide

    Apollo Care recalled semaglutide sterile multi-dose vials in 1.5, 2.5 and 5 mL packages because particles were found in them. Lots AC-017273, AC-017108 and other lots, expiring 8/30/2026 to 5/5/2027, went nationwide in the U.S.

    FDA reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

    Class II: could cause temporary or reversible harm

    About 8.3 million people in the US are prescribed semaglutide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Levothyroxine Sodium (12 products)

    Major Pharmaceuticals, sold nationwide

    Major Pharmaceuticals recalled levothyroxine tablets, 75, 88 and 150 mcg, in 10- and 100-tablet blister cartons after tests found less active ingredient than labeled. Lots N02172A and N02288A and other lots, expiring 07/2026 to 01/2027, were distributed nationwide in the USA.

    FDA reason: Subpotent Drug

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Morphine Sulfate

    Fresenius Kabi USA, sold nationwide

    Fresenius Kabi Morphine 2 mg/mL, 1 mL prefilled syringes were recalled because the label says morphine but the syringe contains Dilaudid 0.5 mg/0.5 mL. Lot 6402820, expiring 12/2028, was sold nationwide in the USA.

    FDA reason: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

    Class I: could cause serious harm or death

    About 590,000 people in the US are prescribed morphine each year.

    The FDA record, with lot numbers (opens in a new tab)

All recalls, last 90 days

539 recalls, newest first

  • Oct. 2, 2026

    Device recall, ongoing

    Verify Biological/Integrator Challenge Pack Model/Catalog Number: Lcb006 and Verify Biological/Integrator Challenge Pack Model/Catalog Number: Lcb007 and 3 more (6 items)

    Steris

    Why: Geobacillus stearothermophilus spore population in affected products may fall below minimum shelf life specification. When used to monitor steam sterilization cycles, the potential hazard is that the biological...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Food recall, ongoing

    Leasa Living Alfalfa Sprouts

    Leasa Industries Co.

    Why: Seeds may have been contaminated with E. coli

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Food recall, ongoing

    Leasa Alfalfa Sprouts

    Leasa Industries Co.

    Why: Seeds may have been contaminated with E.coli

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Beach Chair Surgical Patient Positioner

    Quantum Ops

    Why: Due to a manufacturing issue (inadequate weld) for patient head positioning system.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Spectral Ct and Spectral Ct

    Philips Medical Systems

    Why: Software issues may affect the safety and performance of Spectral CT system(s). The issues may result in image artifacts, wrong slice thickness, or unintended system motion.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Sperm Ab Elisa

    Drg International

    Why: Potential for false negative patient results.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Dxc

    Beckman Coulter

    Why: Beckman Coulter has identified a software issue affecting DxC 500i Clinical Analyzers when testing plasma samples. Following user configuration of a Clinical Chemistry test to use units different from the system...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Dxc

    Beckman Coulter

    Why: Beckman Coulter has identified a software issue affecting DxC 500 AU Clinical Analyzers when testing plasma samples. Following user configuration of a Clinical Chemistry test to use units different from the system...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Halyard Laparoscopy Comprehensive Pack Ii Ref:

    Gri Medical & Electronic Technology Co.

    Why: Laparoscopy packs labeled as "latex free" were found to contain a latex urethral catheter

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Battle Bandage

    Safeguard US Operating

    Why: Compression bandage may be degraded, which may cause unwanted foreign material to be introduced inside the wound, which may lead to wound exploration and irrigation, formation of scar tissue, and infection.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Presource Packs Containing Medtronic Microstream Components: Intubation Kit Cata

    Cardinal Health 200

    Why: Kits contain Microstream components. Medtronic issued an update to the Instructions for Use of these components due reports of difficulty in disconnecting the adapter from the patient's endotracheal tube to perform a...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Glypto Device

    Limitless Cryo Spa

    Why: Lack of 510(k) clearance.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 2, 2026

    Device recall, ongoing

    Generic Name: Kit

    Medical Action Industries, Inc. 306

    Why: An internal data-entry error caused kit lot 333606 to be labeled with an expiration date of March 31, 2027, instead of February 28, 2027.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Drug recall, ongoing

    Amazon (3 products)

    Aurobindo Pharma USA

    Why: Discoloration: consumer complaints received for discolored tablets

    Not Yet Classified

    About 6.5 million people in the US are prescribed acetaminophen each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Ventstar Resus Neo. Neonatal.

    Draeger

    Why: Potential cracks in the hose, which could lead to leakage or the hose falling off.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories and Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories Mdr107000p (2 items)

    Medline Industries

    Why: Potential fire hazard involving the hand control pendant and associated wiring used with affected beds. Pendant or pendant wiring may overheat, potentially leading to smoking, sparking, melting, burning, or fire....

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Drug recall, ongoing

    Clindamycin Phosphate Foam

    Glenmark Pharmaceuticals Inc., USA

    Why: Defective Container: Firm received customer complaints of damaged and leaking product.

    Not Yet Classified

    About 2.6 million people in the US are prescribed clindamycin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Food recall, ongoing

    Todd'S Seeds Alfalfa Sprouting Seeds and Todd'S Seeds Broccoli & Friends Sprouting Seed Mix - Broccoli and 4 more (6 items)

    Todd'S Seeds

    Why: Products contain alfalfa seed recalled by the supplier and may be contaminated with E. coli and/or Salmonella (downstream recall)

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Disposable Tourniquet Cuff and Disposable Bb Tournquet Cuff and 1 more (64 items)

    Asp Global

    Why: Due to incorrect expiration date on product manufactured between September 2016 to March 2023. Products are labeled with a 10 year shelf life. The correct validated shelf life is 5 years.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Biologic recall, ongoing

    Red Blood Cells

    South Texas Blood & Tissue Center

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who was a resident of a malaria endemic area, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Biologic recall, ongoing

    Pooled Platelets

    South Texas Blood & Tissue Center

    Why: Pooled platelets, collected from a donor who was a resident of a malaria endemic area, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Biologic recall, ongoing

    Cornea (2 items)

    Eversight Illinois

    Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Biologic recall, ongoing

    Cornea

    Eversight Illinois

    Why: Cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Hopkins Telescope

    Karl Storz Endoscopy

    Why: Due to incorrect inside packaging label for eyepiece.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Novaseq

    Illumina

    Why: Retrospectively reported correction for an instrument intended for targeted sequencing of DNA libraries from human genomic DNA used with in vitro diagnostic assays has a server with a security vulnerability.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Systems/Units Containing Affected Software/Sql Beckman Coulter Chemistry Analyze

    Beckman Coulter Mishima K.K.

    Why: Certain AU480 chemistry analyzers, with Windows 10 IoT Enterprise 2021 LTSC PCs, may output the message System Stopped By Fatal Error: DBConnectionError AlarmDB when launching the instrument software, using PC...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Charlotte Claw Screw

    Wright Medical Technology

    Why: Screws, intended for use with polyaxial compression plating system intended for foot osteotomies, was manufactured with missing threads on the screwheads, which if used would prevent a secure rigid engagement with the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Mastisol Skin Adhesive

    Custom Interventional Pain Management

    Why: Due to manufacturing issues with the liquid skin adhesive containing in surgical convenience trays/kits.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Device recall, ongoing

    Atellica Ch Revised C-Reactive Protein

    Siemens Healthcare Diagnostics

    Why: The potential for falsely elevated results.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 1, 2026

    Drug recall, ongoing

    Orbi and Omni Gold Anti-Marks Cream Extra Brightening (2 products)

    Danalvig

    Why: Does Not Meet USP or OTC Monograph: FDA analysis found the skin lightening products to be contaminated with mercury.

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Drug recall, ongoing

    Paroxetine Extended-Release Tablets

    Apotex

    Why: Failed dissolution specifications.

    Class II: could cause temporary or reversible harm

    About 1.7 million people in the US are prescribed paroxetine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Drug recall, ongoing

    Benzoyl Peroxide Wash (2 products)

    Sv Labs Toronto

    Why: Microbial contamination of topical product.

    Class II: could cause temporary or reversible harm

    About 180,000 people in the US are prescribed benzoyl peroxide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Food recall, ongoing

    Coco G'S Courmet Flaming Cheddar Hots

    Coco G'S Snack Foods

    Why: Potential Salmonella contamination.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Food recall, ongoing

    Salata Salad Kitchen Jalapen¿O Avocado Dressing. Keep Refrigerated. Packaged in

    Salata Dressings

    Why: This recall was initiated due to potential Salmonella contamination in diced jalape¿no received from the supplier

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Device recall, ongoing

    Quantum Pureflow Standard Heat Exchanger High Flow (2 items)

    Spectrum Medical Srl

    Why: Due to blood-to-glycol leak in the heat exchanger.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Device recall, ongoing

    Olympus Tripp-Lite P580-025

    Olympus Corporation of the Americas

    Why: While in the high-power operating mode, a video dropout/blackout may occur when using a particular accessory cable.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Device recall, ongoing

    Tandem T:Slim Mobile Application Product Name: T:Slim Mobile Application

    Tandem Diabetes Care

    Why: A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Device recall, ongoing

    Penumbra System

    Penumbra

    Why: Due to manufacturing issues reperfusion catheters may fracture.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Device recall, ongoing

    Philips Medical Systems Technologies Ltd. Spectral Ct

    Philips North America

    Why: The Bolus tracking scan application may crash with a system error message. Bolus Tracker shots may continue to occur even if the contrast threshold is reached. This may result in the patient receiving additional...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Drug recall, ongoing

    Buprenorphine Hydrochloride

    Par Health USA

    Why: Crystallization

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Biologic recall, ongoing

    Anticoagulant Sodium Citrate

    Baxter Healthcare

    Why: Baxter International Inc. is voluntarily recalling one lot of Anticoagulant Sodium Citrate Solution (Lot # Y493475) due to the potential presence of particulate matter identified as fiberglass in the solution....

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Drug recall, ongoing

    Dexmedetomidine HCL in

    Par Health USA

    Why: Presence of Particulate Matter: the particulate was identified as cellulose or stopper material

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    American National Red Cross (the)

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which lacked documentation of time exposed to the Compound Absorption Device (CAD) during pathogen reduction, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 29, 2026

    Food recall, ongoing

    Lior Brand Cinnamon Ground Seasoning

    Galil Importing

    Why: Product contains elevated levels of lead.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Drug recall, ongoing

    Estradiol Gel

    Amneal Pharmaceuticals

    Why: Defective Container; packets were found to be either empty or partially full.

    Class II: could cause temporary or reversible harm

    About 4.1 million people in the US are prescribed estradiol each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Device recall, ongoing

    Intrapulmonary Percussive Ventilation and in-Line Valve and 2 more (7 items)

    Percussionaire

    Why: Labeling updated warning not to use Intrapulmonary percussive ventilation (IPV) in conjunction with volatile anesthetic delivery systems because IPV may alter controlled delivery of volatile anesthetic agents, resulting...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Versiti Illinois

    Why: Apheresis Platelets, Leukocytes Reduced, with a platelet count higher than was acceptable, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Central California Blood Center

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who was not re-entered appropriately after positive testing for Chagas, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Pathogen Reduced Cryoprecipitated Fibrinogen Complex

    Central California Blood Center

    Why: Pathogen Reduced Cryoprecipitated Fibrinogen Complex, collected from a donor who was not re-entered appropriately after positive testing for Chagas, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Department of Defense - Army

    Why: Red Blood Cells, for which arm preparation may have been performed incorrectly, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Whole Blood

    Department of Defense - Army

    Why: Whole Blood, for which arm preparation may have been performed incorrectly, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Liquid Plasma

    Department of Defense - Army

    Why: Liquid Plasma, for which arm preparation may have been performed incorrectly, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Fresh Frozen Plasma

    Department of Defense - Army

    Why: Fresh Frozen Plasma, for which arm preparation may have been performed incorrectly, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Department of Defense - Army

    Why: Red Blood Cells, Leukocytes Reduced, for which arm preparation may have been performed incorrectly, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Apheresis Red Blood Cells

    American National Red Cross (the), Lewis and Clark Region

    Why: Misbranded Apheresis Red Blood Cells, Leukocytes Reduced, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Apheresis Red Blood Cells

    the American National Red Cross

    Why: Misbranded Apheresis Red Blood Cells, Leukocytes Reduced, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the American National Red Cross

    Why: Red Blood Cells, Leukocytes Reduced, which were labeled as antigen negative, but were collected from a donor who subsequently tested antigen positive, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the American National Red Cross South Carolina Region

    Why: Misbranded Red Blood Cells, Leukocytes Reduced, Irradiated, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Apheresis Red Blood Cells

    the American National Red Cross

    Why: Apheresis Red Blood Cells, Leukocytes Reduced, which were labeled as antigen negative, but were collected from a donor who subsequently tested antigen positive, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Cornea

    Eversight

    Why: Corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Biologic recall, ongoing

    Cornea

    Oklahoma Lions Eye Bank

    Why: Corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Drug recall, ongoing

    Zoladex

    Tersera Therapeutics

    Why: Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 28, 2026

    Drug recall, ongoing

    Focus Pi Hypromellose

    Aurolab Trust

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Computed Tomography X-Ray System and Positron Emission Tomography and Computed Tomography System (12 items)

    Shanghai United Imaging Healthcare Co.

    Why: Positron emission tomography and computed tomography x-ray systems have a software problem when Split or Local function is enabled, and multiple RIS exams are merged into a single study, that prevents patient images...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Mr and Smartpath To Dstream for and 4 more (7 items)

    Philips North America

    Why: When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Lifesouth Community Blood Centers

    Why: Leukoreduced Apheresis Platelets product, for which platelet yield did not meet specifications, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Biologic recall, ongoing

    Apheresis Platelets (2 items)

    Lifesouth Community Blood Centers

    Why: Leukoreduced Apheresis Platelets product, for which platelet yield did not meet specifications, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Biologic recall, ongoing

    Apheresis Platelets (2 items)

    Lifesouth Community Blood Centers

    Why: Leukoreduced Apheresis Platelets product, for which platelet yield did not meet specifications, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Lifesouth Community Blood Centers

    Why: Apheresis Platelets, Leukocytes Reduced, Irradiated product, for which platelet yield did not meet specifications, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Lifesouth Community Blood Centers - Montgomery Region

    Why: Apheresis Platelets, Leukocytes Reduced, Irradiated product, for which platelet yield did not meet specifications, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Biologic recall, ongoing

    Cornea

    Eversight Illinois

    Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Biologic recall, ongoing

    Cornea

    Visiongift

    Why: Cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Mckesson Consult Hcg Urine Cassette and Fisher Scientific Sure-Vue Serum/Urine Hcg and 2 more (4 items)

    Alere San Diego

    Why: hCG rapid tests may detect low levels of hCG below the stated assay sensitivity, which may result in false positive result.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Embosphere

    Merit Medical Systems

    Why: Microspheres used in embolization of tumors, prostatic arteries, arteriovenous malformations, and blood vessels may have holes in packaging that may affect the sterile barrier, which if used could lead to infection.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Encor Encompass Breast Biopsy and Tissue Removal System Console

    Bard Peripheral Vascular

    Why: Breast biopsy and tissue removal system may experience the following errors: 1) Probe calibration and /or handheld driver failure (code HH01-00020009) , 2) Pressure sensor (code E01-0054000E), which prompts the user to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Palacos R Pro and Palacos R+G Pro and 2 more (4 items)

    Heraeus Medical Gmbh (Dental Division)

    Why: Potential for monomer liquid leakage.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Philips Intrasight Plus Ref:

    Volcano

    Why: Software system may associate image data from one patient with another patient's record, potentially resulting in incorrect diagnosis or treatment.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Performance Pro and Opportunity Flex and 1 more (3 items)

    American Nitrile Operations

    Why: Gloves may exhibit defects such as tears, missing fingers, and debris. Use of defective gloves may lead to healthcare personnel and patient exposure to infectious pathogens leading to infection or cross-contamination...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Medical Convenience Kits Containing Bd Cliniclean Pericare Wipes Within Bd Urina (3 items)

    American Contract Systems

    Why: Kits contain manufacturer-recalled perineal care (pericare) wipes within urinary catheter trays, which may be contaminated with a lubricant used during the manufacturing process. Use of a contaminated wipe may lead to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Presource Packs Containing Stryker Strykeflow Ps and Ahto Tube Sets: 1) Kit (4 items)

    Cardinal Health 200

    Why: The kits contain tube sets with handpieces that may leak during use. The impacted devices can have the following failures: fluid leakage from the hand piece that can pool on the floor. The impact can range from user...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Olympus M3 Gold Autoclavable Foroblique Telescope and Olympus M3 Gold Autoclavable Lateral Telescope (2 items)

    Olympus Corporation of the Americas

    Why: There are identified discrepancies between the sterilization parameters listed in the Instructions for Use and the sterilization parameters listed in the Japanese package insert.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Noxboxi Nitric Oxide Delivery System. Model Number: Noxbox-I.

    Noxbox

    Why: Potential for irregular oxygen readings due to a manufacturing issue affecting certain oxygen sensors.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Ingenia Blue Seal Se and Blue Seal Xe and Ingenia and 1 more (4 items)

    Philips North America

    Why: When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Ingenia Elition S and Ingenia Elition X.

    Philips North America

    Why: When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Drug recall, ongoing

    Ranolazine Extended-Release Tablets

    Ajanta Pharma USA

    Why: Failed Dissolution Specifications

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Biologic recall, ongoing

    Cornea

    Saving Sight

    Why: Corneas, recovered from donors whose donor eligibility was not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately...

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 25, 2026

    Device recall, ongoing

    Heartsine Samaritan Pad

    Heartsine Technologies

    Why: Products were distributed without the required Maintenance Supplement, which describes an extra check every 3 months in addition to the monthly check.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Device recall, ongoing

    Medline Convenience Kits: 1) Peds Sinus Pack and Medline Convenience Kits: 1) Major Pack and 3 more (5 items)

    Medline Industries

    Why: The kits contain neurological sponges with the potential for unexpected variability of endotoxin levels. Potentially elevated endotoxin levels may present health risks that could require medical intervention, such as...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Food recall, ongoing

    Lemon Alfredo Fettuccine Packed in A Yellow Plastic Sealed Bag with Pink and Bla

    Gias Food

    Why: Contamination with Listeria monocytogenes

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Hcsc-Blood Center

    Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from a donor for whom donor eligibility screening was incomplete, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Hcsc-Blood Center

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor for whom donor eligibility screening was incomplete, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Biologic recall, ongoing

    Pf24 Plasma

    Hcsc-Blood Center

    Why: PF24 Plasma, collected from a donor for whom donor eligibility screening was incomplete, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Biologic recall, ongoing

    Apheresis Red Blood Cells

    Oneblood

    Why: Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Lifestream Blood Bank

    Why: Leukoreduced Red Blood Cells product, which was labeled as leukocytes reduced but was not tested to verify white blood cell count, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    West Tn Regional Blood Center

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were not tested for pH, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    New York Blood Center

    Why: Leukoreduced Apheresis Platelets products, with a platelet count higher than was acceptable, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Device recall, ongoing

    Pro+ Mrs Surface for Versacare and Pro+ (3 items)

    Baxter Healthcare

    Why: There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 24, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Blood Assurance

    Why: Leukoreduced Red Blood Cells product, not labeled with a tag indicating that it contained antibodies, was distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Thyroid

    Vitruvias Therapeutics, sold nationwide

    Vitruvias recalled 30 mg thyroid tablets, 100-count bottles, because testing found more active ingredient than the label states. Lot 504950, expiring 09/30/2026, was sold nationwide. 1955 bottles were recalled.

    FDA reason: Superpotent Drug

    Class I: could cause serious harm or death

    In the news: 43 news outlets covered this recall in the last two weeks.

    About 1.2 million people in the US are prescribed thyroid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Chlorthalidone

    Inventia Healthcare Limited, sold nationwide

    Inventia recalled chlorthalidone 25 mg tablets, 100 per bottle, because they did not dissolve as required, so the body may absorb less drug than intended. Batch RISA24002, expiring 04/2027, was sold nationwide. 13567 bottles were recalled.

    FDA reason: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    In the news: 48 news outlets covered this recall in the last two weeks.

    About 1.3 million people in the US are prescribed chlorthalidone each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Medline Convenience Kits: (7 items)

    Medline Industries, sold nationwide

    Why: The kits contain certain lots of sterile applicators which may contain fungal contamination that may occur under certain environmental conditions, allowing the growth of Aspergillus penicillioides. Contamination of skin...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Statstrip Glucose and B- Ketone Meter. Model No: and Statstrip Glucose Hospital Meter System. Model No: (5 items)

    Nova Biomedical, sold nationwide

    Why: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID)...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Lidocaine

    Sun Pharma /Taro, sold nationwide

    Why: Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

    Class II: could cause temporary or reversible harm

    About 610,000 people in the US are prescribed lidocaine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Automated Impella Controller and Impella Optical Controller with the Below Product Descriptions and Corresponding and 1 more (3 items)

    Abiomed, sold nationwide

    Why: The potential for purge cassette recognition issues due to the failure of the purge flag component of the purge pressure sensor assembly.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Power-Trialysis Short-Term Straight Dialysis Catheter and Duoglide Short-Term Straight Dialysis Catheter (2 items)

    Bard Access Systems

    Why: this is a downstream recall of class I recall RES 98777

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Bd Alaris Pump Infusion Sets

    Bd Switzerland Sarl

    Why: Due to discrepancies in specific attributes in the performance data for infusion sets, which may lead to inappropriate pump performance.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Ref:2b5st Ethicon Endo-Surgery and Ref:B5st Ethicon Endo-Surgery and 4 more (6 items)

    Stryker Sustainability Solutions, sold nationwide

    Why: Reusable access port system may crack or seperate during use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Oncology Sets with Drip Chambers and IV Sets with Drip Chambers and 2 more (8 items)

    Icu Medical, sold nationwide

    Why: Intravascular administration tubing set drip chambers may have black specks potentially due to the plastic molding process leaving discolored polyvinyl chloride (PVC) material within the drip chamber wall that does not...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Scorpio C-Dome Patella 73-2710 73-2910 Scorpio U-Dome Patella 73-311 and Abg I Acetabular Insert Hooded and 10 more (12 items)

    Howmedica Osteonics, sold nationwide

    Why: Affected devices were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five years. Product has the potential for elevated levels of oxidation, which may result in...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Halyard IV Start Kit Non-Sterile Ref: Kriv26-02

    Avid Medical, sold nationwide

    Why: Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which are contaminated with Aspergillus penicillioides

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Nystatin

    Sun Pharmaceutical Industries, sold nationwide

    Why: Failed Stability Specifications

    Not Yet Classified

    About 1.2 million people in the US are prescribed nystatin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Haylard and Haylard Univ Imaging Biopsy Trucustom and 2 more (4 items)

    Avid Medical

    Why: Potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Hemospray Endoscopic Hemostat

    Wilson-Cook Medical, sold nationwide

    Why: Due to issue with endoscope adherence and inability to spray powder. Firm will provide an updated Instruction for Use (IFU).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Percutaneous Insertion Kit (3 items)

    Maquet Cardiopulmonary Gmbh, sold nationwide

    Why: The packaging may not consistently maintain sterile barrier integrity.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Cadd Yellow Medication Cassette Reservoir with Nrfit Connector US Product Cod

    Icu Medical, sold nationwide

    Why: Reservoirs may exhibit medication leakage at the joint between luer connector and tubing. Issue could result in delay or interruption of therapy, under delivery of medication, exposure to infectious or toxic agents, or...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Imager Ii Angiographic Catheters M001314001 Imager Ii/5/St/65/038 Bx5

    Boston Scientific

    Why: Tip may fracture or detach, leading to device fragments remaining within the patient or migrating through the vasculature. Patient impact may include prolonged procedure or life-threatening embolism.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Halyard IV Start Kit Non-Sterile

    Avid Medical

    Why: Convenience kits containing BD ChloraPrep Clear - 1 mL Applicator, which may be contaminated with Aspergillus penicillioides.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    0.9% Sodium Chloride Injection

    Otsuka Icu Medical

    Why: Product Mix-up: Product overwrap labeled as 0.9% SODIUM CHLORIDE Injection, USP may contain a bag of POTASSIUM CHLORIDE Inj.10 mEq

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Fluphenazine HCL Elixir (6 products)

    Safecor Health, sold nationwide

    Why: Failed Stability Specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Carescape Central Station Cscs V3 Mas800 Desktop Part Number

    Ge Medical Systems Information Technologies, sold nationwide

    Why: Device may not resume patient monitoring for at least 3 minutes following system restart. Issue can lead to potential delay in recognition of clinically significant events.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Happiest Baby (2 items)

    Happiest Baby, sold nationwide

    Why: Extra small (ES) and Extra-large (XL) infant sleep sacks have not been reviewed for safety and effectiveness by the FDA.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Centricity Pacs Server V7 and Centricity Pacs V2 and 4 more (6 items)

    Ge Healthcare, sold nationwide

    Why: Under certain conditions historical imaging data migrated from a legacy system may become incorrectly associated with a different patient. If this occurs, studies or images may be displayed under the wrong patient...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Medrad¿ Stellant Flex Syringe Kit Used with Stellant Flex Ct Injection System

    Bayer Medical Care, sold nationwide

    Why: Some devices may not have been properly sterilized due to a manufacturing sterilization issue.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Sunmed Tracheal Tube

    Well Lead Medical Co., sold nationwide

    Why: The 6Fr suction catheter could not pass through the samples smoothly.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Dopamine Hydrochloride

    Pfizer, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Aisys Cs2 with Et Control and Et Control and 2 more (4 items)

    Datex-Ohmeda, sold nationwide

    Why: Anesthesia Delivery Systems containing certain electronic gas mixer assemblies can automatically transition to Alternate O2 control. In Alternate O2 control, the system delivers 100% O2 to the breathing system enabling...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Medline Convenience Kit: Open Heart A Pack

    Medline Industries, sold nationwide

    Why: The kits contain a Retrograde Coronary Sinus Perfusion (RCSP) cannulae that has the potential for a sterile barrier breach. Sterility of the product cannot be assured. If a compromised pouch seal is not identified prior...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Philips Pic Ix Essentials Ref:867093 and Philips Patient Information Center Ix Ref:866389 (2 items)

    Philips North America, sold nationwide

    Why: Due to software malfunction, patient information system may freeze and become unresponsive.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Reign Medical Clench Staple System

    F & A Foundation, sold nationwide

    Why: Bone fixation staple requires a new 510(k); the performance characteristics of this device have not been adequately established.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Captus

    Mirion Technologies (Capintec), sold nationwide

    Why: Potential for failure of the tension bolt which would allow the spring arm to unexpectedly fall to its lowest position, which is approximately 25 inches (63.5 cm) from the ground.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Pi-Cardia Inc. Shortcut Ref: Z-A-20.003-US

    Pi Cardia, sold nationwide

    Why: Transfemoral catheter, positing arm may detached due to weld issue.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Boston Scientific Corporation Stonesmart Connect Console Contents:

    Boston Scientific, sold nationwide

    Why: A subset of power adapters used with the connect console may exhibit higher-than-expected resistance in the electrical grounding path. As a result, the power adaptor may fail electrical safety testing during...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Convenience Kits Myringotomy Pack-Lf Dynj59097a and Convenience Kits Anesthesia Pain Pk League Dynj67925a and 2 more (4 items)

    Medline Industries, sold nationwide

    Why: Kits may exhibit open seals in sterile pouch packaging. Open seal may compromise product sterility. If not detected prior to use, issue may lead to contamination of sterile field or patient infection if product is used.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Noxboxi Nitric Oxide Delivery System.

    Noxbox, sold nationwide

    Why: Potential for oxygen tubing leaks due to failure of the tubing or tubing connection, which may lead to oxygen desaturation.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Rt Montecarlo

    Ptw Freiburg, sold nationwide

    Why: When a bolus is included in a treatment plan and sent for secondary dose calculation, the software accounts for it but does not display this clearly, which may lead users to incorrectly omit the bolus during treatment...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Ewo_02512 and Ewo_02513 (2 items)

    Embecta Medical Ii, sold nationwide

    Why: Retrospectively reported: Pen needles labeled 'For Investigational Use Only' were inadvertently distributed as commercially marketed devices.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Gm Helix Implant

    Straumann USA, sold nationwide

    Why: There is a discrepancy between the product identification on the packaging and the dimensions of the implant contained inside.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Kinos Axiom Total Ankle System with Axiom Psr

    Restor3d, sold nationwide

    Why: Ankle implantation systems were packaged with incorrect patient-specific cutting guides, which may result in: delayed surgery, the need to use standard instrumentation, reduced fixation or poor alignment of implants...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Dash Rapid Pcr Instrument

    Nuclein, sold nationwide

    Why: Due to a software issue

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Blood Culture Collection Venipuncture Kit

    Medical Action Industries, Inc. 306, sold nationwide

    Why: Blood culture convenience kits contain a component subject to a drug recall that due to an an open or incomplete seal on the packaging of the applicator may compromise the component's sterile barrier and if used may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Hcsc-Blood Center

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor for whom donor eligibility screening was incomplete, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Hcsc-Blood Center

    Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from a donor for whom donor eligibility screening was incomplete, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Biologic recall, ongoing

    Pf24 Plasma

    Hcsc-Blood Center

    Why: PF24 Plasma, collected from a donor for whom donor eligibility screening was incomplete, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Volara

    Baxter Healthcare

    Why: Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to firm and testing confirmed devices meet specifications.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Cardioroot Woven Collagen Coated Vascular Graft

    Intervascular, Sas

    Why: Product failed to meet the specified acceptance criteria for Integral Water Permeability (IWP).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    New York Embroidery Studio Trinity Non-Surgical Isolation Gown

    New York Embroidery Studio

    Why: Gowns do not consistently meet the minimum liquid-barrier performance required.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Halyard IV Start Kit Non-Sterile (2 items)

    Avid Medical

    Why: Convenience kits containing BD ChloraPrep Clear - 1 mL Applicator, which may exhibit an open or incomplete seal on the packaging of the applicator.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Clear Eyes Redness Relief (2 products)

    Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Drug recall, ongoing

    Olanzapine Tablets

    Macleods Pharmaceuticals Limited

    Why: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

    Class III: unlikely to cause harm

    About 670,000 people in the US are prescribed olanzapine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Pooled Cryoprecipitated Ahf

    Impactlife

    Why: Pooled Cryoprecipitated AHF, not prepared in accordance with specifications, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the Blood Connection

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who had taken the drug Accutane, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the Blood Connection

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor currently taking Proscar, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the National American Red Cross

    Why: Red Blood Cells, Leukocytes Reduced, which were labeled as antigen negative, but were collected from a donor who subsequently tested antigen positive, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Red Blood Cells

    American National Red Cross (the), Lewis and Clark Region

    Why: Misbranded Red Blood Cells, Leukocytes Reduced, Irradiated, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Penn State Health Holy Spirit Medical Center

    Why: Red Blood Cells, Leukocytes Reduced, with incomplete testing, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Bone

    Tissue Transplant Technology

    Why: Bone products, processed in a manner that could cause contamination, cross-contamination, or the introduction, transmission, or spread of communicable disease, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Cornea

    Lions Eye Bank of Nebraska

    Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Cornea

    San Antonio Eye Bank

    Why: Mislabeled cornea was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Cornea

    Onelegacy

    Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Cornea

    Eversight Illinois

    Why: Cornea, recovered from a donor in which donor eligibility was not adequately determined, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Cornea

    Onelegacy

    Why: Corneas, recovered from donors in which donor eligibility was not adequately determined, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Device recall, ongoing

    Ngenuity Patient Monitor with Capnography

    Criticare Technologies

    Why: Complaint trend where "Checkline Error" alarm presents at device setup, rendering the CO2 monitoring function inoperable. May result in procedure delay.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Device recall, ongoing

    Presource Convenience Kits: 1) Kit (2 items)

    Cardinal Health 200

    Why: The kits contain applicators that may exhibit an open or incomplete seal on the packaging of the applicator. Use of a potentially contaminated applicator could result in no patient harm or may lead to localized skin or...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Device recall, ongoing

    Ref:

    Deroyal Industries

    Why: Myocardial temperature probes contain an incorrect needle. Specifically, an 18mm needle was included instead of a 15mm needle.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Drug recall, ongoing

    Exenatide Injection

    Amneal Pharmaceuticals of New York

    Why: Defective Delivery System: Possibility of no medication in the prefilled pen.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Carter Bloodcare

    Why: Red Blood Cells, Leukocytes Reduced, which were leukoreduced by filtration at an unacceptable temperature, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    the American National Red Cross South Carolina Region

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were out of monitored storage for an extended period of time, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the American National Red Cross South Carolina Region

    Why: Red Blood Cells, Leukocytes Reduced, which were out of monitored storage for an extended period of time, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 22, 2026

    Biologic recall, ongoing

    Cornea

    South Dakota Lions Eye Bank

    Why: Corneas, recovered from a donor who was not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Drug recall, ongoing

    Avkare Carboxymethylcellulose Sodium Ophthalmic Solution and Reliable -1 Laboratories and 5 more (9 products)

    Sterling Pharmaceutical Services

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea

    Eversight Illinois

    Why: Cornea, processed without conducting the proper antibiotic soak, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Lifesouth Community Blood Centers

    Why: Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced product, for which platelet yield did not meet specifications, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Mississippi Blood Services

    Why: Red Blood Cells, Leukocytes Reduced, collected from an unsuitable donor due to a donor screening deviation, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Mississippi Blood Services

    Why: Leukoreduced Red Blood Cells products, collected from a donor with hemoglobin lower than was acceptable, or who had no hemoglobin check performed during screening, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Department of Defense - Air Force

    Why: Red Blood Cells product, collected from a donor who previously tested repeatedly reactive for the antibody to Human T-Lymphotropic Virus (HTLV-I), was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the Blood Center

    Why: Red Blood Cells, Leukocytes Reduced, incorrectly labeled as irradiated, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Vitalant

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who provided travel history to a malaria endemic area, but was not assessed for residency, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    the American National Red Cross

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were not tested for pH or platelet yield, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Whole Blood

    Department of Defense - Navy

    Why: Whole Blood, which tested negative for the antibody to the Human T-Lymphotropic Virus (Anti-HTLV) but was collected from a donor who previously tested repeatedly reactive for anti-HTLV, Western blot positive, was...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Arup Laboratories

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor taking an unlicensed, unapproved, or experimental medication, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea

    Corneagen - Boston

    Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea (2 items)

    Precision Ocular Network - Bartlett

    Why: Corneas, recovered from a donor in which donor eligibility was not adequately determined, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea

    Eversight

    Why: Cornea, recovered from a donor in which donor eligibility was not adequately determined, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea

    Rocky Mountain Lions Eye Bank

    Why: Corneas, recovered from donors in which donor eligibility was not adequately determined, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea

    Onelegacy

    Why: Corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea

    Corneagen - Boston

    Why: Corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea

    Iowa Lions Eye Bank

    Why: Corneas, processed using an expired viewing chamber, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Device recall, ongoing

    Foresight Elite Tissue Oximetry Cable Ref Hemfsm10 Udi-Di Code:

    Becton, Dickinson and

    Why: Due to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Hcsc-Blood Center

    Why: Apheresis Platelets, Leukocytes Reduced, which were exposed to unacceptable storage temperatures, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 21, 2026

    Biologic recall, ongoing

    Cornea

    Eversight Illinois

    Why: Corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Inca (2 items)

    Coopersurgical

    Why: Potential to exhibit a loose connection between the flexible tubing and the nasal cannula, during assembly or while in use, which may result in loss of CPAP pressure, possibly reducing the effectiveness of treatment and...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Achieva and Achieva XR and 7 more (12 items)

    Philips North America

    Why: A software issue will terminate an examination during the image reconstruction process if the scan parameters are manually adjusted such that reconstruction requirements exceed the available system memory.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Food recall, ongoing

    Evergreen Fresh Sprouts LLC

    Evergreen Fresh Sprouts

    Why: Salmonella

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Spectralis with Flex Module

    Heidelberg Engineering Gmbh

    Why: Wheels may come loose when module is being pushed or pulled during movement or transportation, affecting stability of the stand. The stand may tip over as a result. Falling stand may cause impact or crushing injuries...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Olympus Bicoag Hemostasis Probe (4 items)

    Olympus Corporation of the Americas

    Why: Potential for detachment of ceramic tip due to manufacturing without the designated amount of adhesive.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Olympus Ezdilate Endoscopic Balloon Dilator Wired-Guided

    Olympus Corporation of the Americas

    Why: Potential for the inflation chart label affixed to the shaft of the device to be incorrect and indicate a balloon diameter of 18, 19, or 20 mm,

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Midmark Iqvitals Zone (4 items)

    Midmark

    Why: A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Hf2p0st9 Homefill Oxygen System Homefill Cylinder M9 with Cga870 Compatible Post and Ref:Hf2pc9 Homefill Oxygen System and 1 more (3 items)

    Ventec Life Systems

    Why: Labeling; Oxygen Cylinders do not contain required medical gas labeling

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Extended Polyaxial Head

    Seaspine Orthopedics

    Why: The proximal thread depth of the spinal device is out of design specification.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Powerled

    Maquet Sas

    Why: The potential for the device to detach at the junction between the spring arm and suspension arm and fall causing potential injury.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Combiset Hemodialysis Blood Tubing Set with Attached Priming Set and Transducer

    Fresenius Medical Care Renal Therapies Group

    Why: Communication to recommend reviewing the IFU and ensuring that all treatment preparation and handling steps are performed as instructed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Philips Epiq Elite Diagnostic Ultrasound System Model #

    Philips Ultrasound

    Why: Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Medline Convenience Kits Containing Healthmark Instrument Channel Brushes. Sinus and Medline Convenience Kits Containing Healthmark Instrument Channel Brushes. Sinus (2 items)

    Medline Industries

    Why: Kits contain Healthmark Instrument Channel Brushes, which were recalled by the manufacturer due to the potential for a sharp edge/burr on the end of the brush. Potential hazards associated include cut injury/abrasion...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Vitek

    Biomerieux

    Why: The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Device recall, ongoing

    Coopervision

    Why: A small number of lenses within the affected lot are of the incorrect power.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Drug recall, ongoing

    Menow Sunscreen Pressed Powder Spf35 Pa+++

    Shantou Qiwei Industrial Co.

    Why: cGMP Deviations

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 18, 2026

    Food recall, ongoing

    Pecorino Toscano D.O.P. Stagionato Cheese Wheels. Product of Italy. Each Cheese

    Elegant Foods

    Why: Potential Listeria contamination from dripping condensation in cooler.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 17, 2026

    Food recall, ongoing

    Mon Sire Brie

    Optimus Inc. D/B/A/ Markys Caviar

    Why: The firm was notified by their Brie Cheese supplier that sample results revealed the presence of Listeria monocytogenes.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Epinephrine

    American Regent, sold nationwide

    Why: Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

    Class I: could cause serious harm or death

    About 1.1 million people in the US are prescribed epinephrine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Sodium Chloride

    B Braun Medical, sold nationwide

    Why: Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Bravo Cf Capsule Delivery Device

    Given Imaging, sold nationwide

    Why: Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Dextrose Injection

    Baxter Healthcare, sold nationwide

    Why: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Products That Contain the Pericare Wipes: Surestep" Foley Tray System Add-A-Fol and Products That Contain the Pericare Wipes: Bard¿ Foley Tray with Lubri-Sil¿ All- and 4 more (6 items)

    C.R. Bard, sold nationwide

    Why: Due to complaints received indicating presence of contamination on the surface of pericare wipes provided with various Foley and Intermittent Catheter Trays.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Kit: Single Shot Epidural and Kit: Epidural/Pain Tqc (2 items)

    Medical Action Industries, Inc. 306

    Why: Kits containing Sodium Chloride ampules subject to another recall are recalled due to potentially compromised sterility.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Medicalyte Liquid Bicarbonate Concentrate Ref: Bc-100 and Bc+201 and Citric Complete Liquid Citric Acid Concentrate Ref: Lc+200-D and 2 more (4 items)

    Nipro Renal Soultions USA, sold nationwide

    Why: Hemodialysis concentrates contain high endotoxin levels

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Heartsine Sam

    Heartsine Technologies, sold nationwide

    Why: Due to a damaged (over stretched) membrane tail that causes an intermittent fault.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Food recall, ongoing

    Pico De Gallo-Mild-4oz Pico De Gallo-Mild-6/14oz Pico De Gallo-4/5# Pico De Gall and Soup Mix-6/58oz Tray and 6 more (8 items)

    Naturebest Pre-Cut & Produce

    Why: Jalapenos have the potential to be contaminated with Salmonella

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Fentanyl Citrate

    Ourpharma, sold nationwide

    Why: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Fluphenazine Hydrochloride

    Ajanta Pharma USA, sold nationwide

    Why: Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Dermav Laser System

    Lutronic, sold nationwide

    Why: Utilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in patient burn.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Getinge Pvc Thoracic Catheter (3 items)

    Atrium Medical, sold nationwide

    Why: An Out of Specification result (OOS) related to bacterial endotoxin testing in a single lot of catheters.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Ams Convenience Kit: Dsaek Pack - Rx

    Windstone Medical Packaging, sold nationwide

    Why: The convenience kits contain .0.9% Sodium Chloride Injection, USP products in Single Dose freeflex bags, which may contain blue Break-off-Parts (BOPs) that have detached from the infusion port during manipulation.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Halyard IV Start Kit Non-Sterile Ref: Kriv26-02

    Avid Medical, sold nationwide

    Why: Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which lacks sterility assurance due to to wrinkles in the paper lidding which may breach the seal area.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Food recall, ongoing

    Organic Triple Berry Blend Strawberries

    Frutas Y Hortalizas Del Sur S.A.

    Why: Potential E. coli O145:H28 Contamination

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Biologic recall, ongoing

    Red Blood Cells

    American National Red Cross (the)

    Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected in a manner that compromises the sterility of the collection system, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Biologic recall, ongoing

    Pf24 Plasma

    American National Red Cross (the)

    Why: PF24 Plasma, collected in a manner that compromises the sterility of the collection system, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Biologic recall, ongoing

    Red Blood Cells

    American National Red Cross (the)

    Why: Red Blood Cells, Leukocytes Reduced, collected in a manner that compromises the sterility of the collection system, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Povidone Iodine

    Imprimisrx Nj, sold nationwide

    Why: Subpotent Drug

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Drug recall, ongoing

    Nystatin Cream

    Sun Pharmaceutical Industries

    Why: Failed Stability Specifications

    Class II: could cause temporary or reversible harm

    About 1.2 million people in the US are prescribed nystatin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Food recall, ongoing

    Diced Jalapenos. Ingredients: Jalapeno Pepper. Net Wt: and Rice & Bean Burrito. Ingredients: Rice and 21 more (25 items)

    Taylor Fresh Foods

    Why: Potential contamination with Salmonella.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the American National Red Cross

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Biologic recall, ongoing

    Pooled Cryoprecipitated Ahf

    the American National Red Cross

    Why: Pooled Cryoprecipitated AHF, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Biologic recall, ongoing

    Red Blood Cells

    American Natl. Red Cross-Greater Chesapeake & Potomac Region

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who provided travel history to a malaria endemic area, but was not assessed for residency, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Biologic recall, ongoing

    Apheresis Pf24rt24 Plasma

    American National Red Cross Blood Services Sw Region

    Why: Apheresis PF24RT24 Plasma, collected in a manner that compromises the sterility of the collection system, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Innovative Blood Resources

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, was distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Drug recall, ongoing

    Phytonadione Injectable Emulsion

    Amneal Pharmaceuticals of New York

    Why: Failed Impurities/Degradation Specifications

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 15, 2026

    Food recall, ongoing

    Martina Brand Fresh Whole Mangoes

    Panorama Produce Sales

    Why: Product may be contaminated with Salmonella

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 14, 2026

    Food recall, ongoing

    Everything Sprouts and Calco Branded Alfalfa Sprouts and Everything Sprouts Zesty Garlic Mix and 2 more (4 items)

    Everything Sprouts

    Why: Sprouts may be contaminated with STEC E. coli and/or Salmonella.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 14, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Lifeshare Blood Center

    Why: Apheresis Platelets, Leukocytes Reduced, with a platelet count higher than was acceptable, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 14, 2026

    Biologic recall, ongoing

    Plasma Frozen

    New York Blood Center Enterprises

    Why: Plasma Frozen, collected in an expired collection kit, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 14, 2026

    Biologic recall, ongoing

    Red Blood Cells

    New York Blood Center Enterprises

    Why: Red Blood Cells, Leukocytes Reduced, Irradiated, collected in an expired collection kit, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 14, 2026

    Biologic recall, ongoing

    Red Blood Cells

    New York Blood Center Enterprises

    Why: Red Blood Cells, Leukocytes Reduced, collected in an expired collection kit, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 14, 2026

    Biologic recall, ongoing

    Liquid Plasma

    New York Blood Center Enterprises

    Why: Liquid Plasma, collected in an expired collection kit, was distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Clindamycin Phosphate and Vasopressin in 0.9% Sodium Chloride and 8 more (17 products)

    Baxter Healthcare, sold nationwide

    Why: CGMP Deviations

    Class II: could cause temporary or reversible harm

    About 2.6 million people in the US are prescribed clindamycin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Trazodone Hydrochloride

    Teva Pharmaceuticals USA, sold nationwide

    Why: Presence of Foreign Tablets/Capsules

    Class II: could cause temporary or reversible harm

    About 6.4 million people in the US are prescribed trazodone each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Glutathione

    Optimal Balance Pharmacy, sold nationwide

    Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

    Class I: could cause serious harm or death

    About 300,000 people in the US are prescribed ascorbic acid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Chlorhexidine Gluconate

    Sage Products, sold nationwide

    Why: Cross Contamination with Other Products

    Class II: could cause temporary or reversible harm

    About 960,000 people in the US are prescribed chlorhexidine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Sodium Chloride

    Baxter Healthcare

    Why: Presence of particulate matter: Particulates identified as fiberglass

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Mycophenolate Mofetil

    Mylan Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    About 160,000 people in the US are prescribed mycophenolate mofetil each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Trokendi XR

    Supernus Pharmaceuticals, sold nationwide

    Why: Failed dissolution specifications.

    Class III: unlikely to cause harm

    About 2 million people in the US are prescribed topiramate each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Medline Convenience Kits: (16 items)

    Medline Industries, sold nationwide

    Why: The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Medline Convenience Kits Containing Bd Chloraprep Clear - (13 items)

    Medline Industries, sold nationwide

    Why: Convenience kits contain BD ChloraPrep Clear - 1mL Applicators from specific lots that were recalled by the manufacturer because they may have an open or incomplete seal on the applicator packaging. Use of potentially...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Healon Endocoat Pro

    Johnson & Johnson Surgical Vision, sold nationwide

    Why: Surgical instructions sent for viscoelastic products used during ophthalmic viscosurgical cataract procedures including in part: If resistance is encountered during insertion, withdraw cannula and reassess the insertion...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    the One Spf (4 products)

    Allies Group, sold nationwide

    Why: Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Prasugrel

    Mylan Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Halyard Medical Convenience Kits Labeled As: and 1) Neuro (3 items)

    Avid Medical, sold nationwide

    Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Presource Packs Containing Cliniclean Pericare Wipes Within Bd Urinary Catheter (12 items)

    Cardinal Health 200, sold nationwide

    Why: The Urinary Catheter Trays contain CliniClean Pericare Wipes which may potentially be contaminated with a lubricant used during the manufacturing process. If a contaminated wipe is used on a patient, localized skin...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    5008x Hd/Hdf with Twister Blood Tubing Set Part Number and 5008x Standard Hd Pre-Flush Standard Blood Tubing Set Part Number and 2 more (4 items)

    Fresenius Medical Care Renal Therapies Group, sold nationwide

    Why: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Granuflo Dry Acid Concentrate: Product Numbers: and Naturalyte and 1 more (3 items)

    Fresenius Medical Care Renal Therapies Group, sold nationwide

    Why: Complaints of blue-green discoloration in product

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Baxter Novum Iq Syringe Pump (2 items)

    Baxter Healthcare, sold nationwide

    Why: A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Discofix Four Way Stopcock

    B Braun Medical, sold nationwide

    Why: Specific lots of Discofix Stopcock Sets recalled due to an incorrect expiration date printed on the carton shipper label.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Doxylamine Succinate and Pyridoxine Hydrochloride

    Bionpharma, sold nationwide

    Why: Presence of Foreign Tablets/Capsules

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Prasugrel

    Golden State Medical Supply, sold nationwide

    Why: Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Sta Staclot Protein S

    Diagnostica Stago, sold nationwide

    Why: A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Lux-Dx (3 items)

    Boston Scientific, sold nationwide

    Why: There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Velys Enabling Tech Robotic-Assist Station Ref:

    Medos International Sarl, sold nationwide

    Why: Software issue within robotic controller which may cause unintended movement of the robotic arm during bone preparation or instrument positioning.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Buprenorphine

    American Health Packaging, sold nationwide

    Why: Labeling: Label Mix-up

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Broadway Joe'S Pain Cream (2 products)

    Lexia

    Why: CGMP Deviations: Potential contamination of raw material

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Philips Brilliance Ct and Philips Ingenuity Ct Product Codes: Ingenuity Ct Upgrades and 2 more (4 items)

    Philips North America

    Why: Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Elapegademase-Lvlr

    Chiesi USA

    Why: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Levothyroxine Sodium (12 products)

    Accord Healthcare, sold nationwide

    Levothyroxine Sodium Tablets, USP, 200 mcg in 90- and 1000-count bottles and 50, 125 and 25 mcg in 1000-count bottles, were recalled because testing found less active ingredient than labeled. Lots D2402430 and D2402431 and other lots, expiring from 08/31/2026 to 01/31/2027, were distributed nationwide.

    FDA reason: Subpotent Drug

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride

    B Braun Medical, sold nationwide

    B. Braun Lactated Ringer's Injection USP, 1000 mL EXCEL container, was recalled because particles that do not belong in the product were found. Lot J4H077, expiring 30NOV2026, was distributed nationwide. 23,688 bags were recalled.

    FDA reason: Presence of Particulate matter.

    Class I: could cause serious harm or death

    About 4.1 million people in the US are prescribed potassium chloride each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Ramipril

    Hikma Pharmaceuticals USA, sold nationwide

    Why: Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

    Class II: could cause temporary or reversible harm

    About 440,000 people in the US are prescribed ramipril each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Clobetasol Propionate

    Lupin Pharmaceuticals, sold nationwide

    Why: Failed content uniformity specifications.

    Class II: could cause temporary or reversible harm

    About 2.2 million people in the US are prescribed clobetasol each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Paxil Cr

    Apotex, sold nationwide

    Why: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria

    Class II: could cause temporary or reversible harm

    About 1.7 million people in the US are prescribed paroxetine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Tocilizumab-Aazg

    Fresenius Kabi USA, sold nationwide

    Why: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Zicam

    Church & Dwight Co., sold nationwide

    Why: CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Medline Breathing Circuits Labeled As: and Medline Hudson Rci (3 items)

    Medline Industries, sold nationwide

    Why: Neonatal and infant heated wire breathing circuits may experience sporadic failure. The heated wire connector (pigtail) at the humidifier may exhibit discoloration, melting, smoke, burning odor, or other signs of...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Onli

    Hollister Ulc, sold nationwide

    Why: Hollister has identified that select lots of the catheters identified in the above table may exhibit a protrusion caused by a manufacturing defect which might lead to genitourinary trauma or bleeding.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Repository Corticotropin

    Mallinckrodt Hospital Products, sold nationwide

    Why: Presence of particulate matter: glass and stopper piece

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Medline Convenience Kits Labeled As: and Medline Convenience Kits Labeled As: Ltp Cds-Lf and 1 more (11 items)

    Medline Industries, sold nationwide

    Why: Kits contain a potentially contaminated component which were recalled by the manufacturer

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Halyard Total Joint Model/Catalog Number: Msbm036-03 and Davinci Trucustom Bundle Containing Tray Foley (7 items)

    Avid Medical, sold nationwide

    Why: Labeling Deficiency: The medical kit labeling fails to identify that the statlock component contains natural rubber latex.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Ort200 and Ort300 (2 items)

    Imris Imaging, sold nationwide

    Why: The linear actuator and rotational lock mechanism components may experience a mechanical failure that prevents the system from transitioning between locked and unlocked state. This may pose a risk of injury to the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Powerseal

    Olympus Corporation of the Americas, sold nationwide

    Why: Potential labeling deficiency in which an outer shelf box is incorrectly labeled as a 37-cm device.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Fresenius Medical Care

    Fresenius Medical Care Renal Therapies Group, sold nationwide

    Why: Fresenius Medical Care Renal Therapies Group, LLC (FMCRTG) has received complaints regarding flow-, no water-, or temperature-related alarms with the 2008T¿ BlueStar Hemodialysis machines.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Merge Pacs and Merge Orthopacs

    Merge Healthcare, sold nationwide

    Why: Software issue may cause measurements to be displayed inaccurately.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Alphenix Models Infx-8000c Infx-8000f Infx-8000v This Device Is A Digital

    Canon Medical System, USA, sold nationwide

    Why: Due to the fixing screws of ceiling movement gear in ceiling suspended arm that are part of the X-ray interventional systems may become loose.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Medline Medical Convenience Kits (4 items)

    Medline Industries, sold nationwide

    Why: Specific item(s) and lot(s) of Medline convenience kits containing Pilling Wecksorb Neurosponges and Neurosponge Strips are being recalled due to potential out-of-specification levels of endotoxin of the neurosponges.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    American Contract System Convenience Kit and American Contract System Convenience Kits (4 items)

    American Contract Systems, sold nationwide

    Why: The Convenience Kits contain Medline's Red Rubber Intermittent Catheters (8Fr-22 Fr) and Red Rubber Intermittent Catheter Trays. Medline Industries, LP has identified representative samples did not meet applicable...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Medline Medical Convenience Kit Labeled As: Trach Tube Kit

    Medline Industries, sold nationwide

    Why: Component labeling discrepancy

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Midmark Digital Ecg Hd+12 and Midmark Iqecg Digital Ecg (2 items)

    Midmark, sold nationwide

    Why: A communication anomoly may result in incorrect electrocardiogram waveforms of a patient and an inaccurate beats-per-minute calculation.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Structur and Grandio Universal Nano-Hybrid Restorative Material - Capsules (2 items)

    Henry Schein, sold nationwide

    Why: Specific lots were distributed in the US with incorrect packaging and Instructions for Use (IFU) from the U.S. FDA-cleared device.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Conmed Linvatec Genesys Crossft Suture Anchor with Disposable Driver Ref# Cfbc

    Conmed, sold nationwide

    Why: Suture anchor may contain incorrect patient implant card which may result in incorrect device identification and traceability.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Healthmark Prochek-Ii and Healthmark Prochek-W Protein Test for Robotic Arms (2 items)

    Healthmark Industries Co., sold nationwide

    Why: Test manufactured with an expired ingredient which may present as either a false negative or positive.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Fujifilm Synapse Pacs Software V7.4.310

    Fujifilm Healthcare Americas, sold nationwide

    Why: Software issue may cause the ruler measurement to be inaccurate.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Philips Incisive Ct with Software V4.5&V5.0

    Philips Healthcare (Suzhou) Co., sold nationwide

    Why: Potential of failing to trigger clinical scan during Bolus Tracking.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Portrait Core Services Software V1.0.5 and Portrait Compute and Core Services V1.2 and 2 more (4 items)

    Ge Medical Systems Information Technologies

    Why: Software issue may result in a loss of patient monitoring at the Hub and Central Viewer. In addition, all alarm settings could be reset to factory defaults following the update and will not follow the alarm settings...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Cyanocobalamin and Trace Elements Injection 4 and 7 more (12 products)

    American Regent, sold nationwide

    American Regent recalled cyanocobalamin 10,000 mcg/10 mL injection, Multrys 1 mL vials, acetylcysteine 20% 4 mL vials and papaverine 60 mg/2 mL injection vials because unwanted particles were found. Lots 25082, 25163 and other lots, expiring 9/30/2026 to 8/31/2027, went nationwide in the U.S.

    FDA reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

    Class I: could cause serious harm or death

    About 1.8 million people in the US are prescribed cyanocobalamin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Morphine Sulfate

    Fresenius Kabi USA, sold nationwide

    Fresenius Kabi Morphine 2 mg/mL, 1 mL prefilled syringes were recalled because the label says morphine but the syringe contains Dilaudid 0.5 mg/0.5 mL. Lot 6402820, expiring 12/2028, was sold nationwide in the USA.

    FDA reason: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

    Class I: could cause serious harm or death

    About 590,000 people in the US are prescribed morphine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Boston Scientific Enroute Transcarotid Neuroprotection System Plus and Boston Scientific Enroute Transcarotid Neuroprotection System (2 items)

    Boston Scientific, sold nationwide

    Why: Potential for arterial sheath tip separation or partial tip separation during use.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Carbamazepine

    Golden State Medical Supply, sold nationwide

    Why: CGMP deviations: tablets with black specks.

    Class II: could cause temporary or reversible harm

    About 420,000 people in the US are prescribed carbamazepine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Carbamazepine Tablets

    Sun Pharmaceutical Industries, sold nationwide

    Why: CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

    Class II: could cause temporary or reversible harm

    About 420,000 people in the US are prescribed carbamazepine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Bmc/Reacthealth Luna G3 Apap Ref Lg

    Bmc Medical Co.

    Why: Retroactive reporting for 2024 rework conducted at the 3B/React Health warehouse

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Bd Needle Kit for Powered Driver

    Bard Access Systems

    Why: After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Overstitch Suture Cinch and Suture Cinch Long (2 items)

    Boston Scientific, sold nationwide

    Why: Device may fail to deploy the cinch implant and/or fail to cut the suture as intended.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Esteem Body Soft Convex Urostomy Pouch Model/Catalog Numbers:

    Convatec, sold nationwide

    Why: Urostomy Pouches may leak from cap during use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Pemetrexed Disodium (2 products)

    Shilpa Medicare Limited, sold nationwide

    Why: Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Cemiplimab-Rwlc

    Regeneron Pharmaceuticals, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    One-Piece Guedel Airway (2 items)

    Intersurgical, sold nationwide

    Why: Devices could potentially be occluded or partially occluded.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Acamprosate Calcium Enteric-Coated

    Mylan Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Halyard Lavh Pack

    Avid Medical, sold nationwide

    Why: The kit component was subjected to EO sterilization, contrary to the manufacturer recommendation, which may have led to the component leaking in a kit.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Beckman Coulter and Syva Emit (2 items)

    Siemens Healthcare Diagnostics, sold nationwide

    Why: Due to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Blanketrol Ii Model and Blanketrol Iii and 1 more (3 items)

    Gentherm Medical, sold nationwide

    Why: Overheating of the 115V CPU board may cause the device to shut down.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Veritas Standard Glenoid Baseplate

    Restor3d, sold nationwide

    Why: Due to incorrect machining of peripheral screw hole resulting in potential for improper engagement of the peripheral screws.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Paragonix Technologies Inc. Kidneyvault Portable Renal Perfusion System Ref# Pr

    Paragonix Technologies, sold nationwide

    Why: Due to a firmware defect, the portable organ transfer device datalogger may lose its configuration, resulting in a blank screen and loss of displayed preservation parameters.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Td Navio Midi Speech Generating Device Model/Catalog Number: and Td Navio Maxi Speech Generating Device Model/Catalog Number: (2 items)

    Tobii Dynavox, sold nationwide

    Why: Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Hamilton Microlab Star Liquid Handler

    Foundation Medicine, sold nationwide

    Why: Software issue that can cause an increase in spontaneous software closures.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Cardiac Workstation (2 items)

    Philips North America, sold nationwide

    Why: Device will intermittently provide inaccurate data related to native heart rate.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Siemens Healthineers Immulite (2 items)

    Siemens Healthcare Diagnostics Products, sold nationwide

    Why: Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Endoflip System That Includes: Endoflip

    Covidien, sold nationwide

    Why: The system's 24-hour usage limit results in catheters incorrectly flagged as expired, making them unavailable for clinical procedures.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Beckman Coulter Dxc (2 items)

    Beckman Coulter, sold nationwide

    Why: a software defect in which the Parameter Package (PP) import logic overwrites all predefined calculated test rules, including those previously modified by the user, upon import of a new Parameter Package version. As a...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Fort Defiance Industries

    Fort Defiance Industries, sold nationwide

    Why: The Automated Field Steam Sterilizer's water recovery system 120V Amphenol connector may experience an intermittent loss of ground continuity, which could result in an unreliable fault current return path.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Arrow-Lok Implant

    Arrowhead De, sold nationwide

    Why: Implant did not undergo required gamma radiation dose audit. A potential reduction in sterility assurance could lead to patient infection.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Getinge Y Sensor Module

    Maquet Critical Care Ab, sold nationwide

    Why: The module did not undergo electrical safety tests and functional tests during production.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    American Contract Systems Medical Procedure Kits and Trays Labeled As: (2 items)

    American Contract Systems

    Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Arvis Surgical Navigation System Gen

    Kico Knee Innovation

    Why: Due to an internal sensor issue, image displayed with eyepiece may appear tilted relative to the eyepiece housing

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Minimed (3 items)

    Medtronic Minimed

    Why: Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Lago X and Ami Htx (2 items)

    Spectral Instruments

    Why: Momentary absence of On-Screen "X-Ray On" banner during run readiness check.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Dentsply Sirona Capsule Mixer Model No.

    Sdi Limited

    Why: Potential for electrical discharge from unit when unplugged.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Custom Made Device Implant (2 items)

    Paragon 28, sold nationwide

    Why: Device was recalled due to an elevated oxygen level in excess of the allowable limit. Elevated oxygen levels may contribute to reduced material ductility.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Semaglutide (11 products)

    Apollo Care, sold nationwide

    Apollo Care recalled semaglutide sterile multi-dose vials in 1.5, 2.5 and 5 mL packages because particles were found in them. Lots AC-017273, AC-017108 and other lots, expiring 8/30/2026 to 5/5/2027, went nationwide in the U.S.

    FDA reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

    Class II: could cause temporary or reversible harm

    About 8.3 million people in the US are prescribed semaglutide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Sildenafil Citrate USP and Tadalafil USP (5 products)

    Shoolin Pharma Chem L, sold nationwide

    Why: CGMP Deviations:Noted during FDA inspection

    Class II: could cause temporary or reversible harm

    About 1.4 million people in the US are prescribed tadalafil each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Glutathione

    Victory Medical Center Pharmacy, sold nationwide

    Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

    Class I: could cause serious harm or death

    About 300,000 people in the US are prescribed ascorbic acid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Clindamycin Palmitate Hydrochloride

    Heritage Pharmaceuticals, sold nationwide

    Why: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

    Class II: could cause temporary or reversible harm

    About 2.6 million people in the US are prescribed clindamycin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Valsartan

    Novartis Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    About 2.6 million people in the US are prescribed valsartan each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Cefazolin in Dextrose

    Baxter Healthcare, sold nationwide

    Why: Presence of Particulate Matter

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Baxter Duo-Vent Solution Set and Male Luer Lock Adapter

    Baxter Healthcare, sold nationwide

    Why: Baxter received customer reports of air bubbles in the drip chamber and tubing when a pressure cuff is in use or when the tubing is flushed at the fully open position.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Ioversol

    Liebel-Flarsheim Company, sold nationwide

    Why: Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Cardinal Health Presource Kits: (8 items)

    Cardinal Health 200, sold nationwide

    Why: Procedure kits contain MEDICOM Ritmed Neurological Sponges that were recalled due to unexpected variability in endotoxin levels.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    V-Loc and Surgipro Ii S8698gx Surgipro Ii Bl and 2 more (5 items)

    Covidien, sold nationwide

    Why: Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Kian Pee Wan Capsules

    Buy-Herbal

    Why: Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Medline Micro-Kill Bleach Germicidal Bleach Wipes (4 items)

    Medline Industries, sold nationwide

    Why: Medline Micro-Kill Bleach Germicidal Bleach Wipes may exhibit a reduction in bleach concentration to levels below specification prior to the end of the labeled 12-month shelf life. Reduced bleach concentration may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Sodium Chloride Injection

    Spectra Medical Devices

    Why: Manufacturing firm, Huons, was cited for issues regarding product quality and sterility assurance. If the product sterility is compromised, patients may be exposed to microorganisms, endotoxins, or foreign matter. This...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Boston Scientific Enhance Transcarotid/Peripheral Access Kit Ref: SR-4f21g7d-Mp

    Galt Medical, sold nationwide

    Why: Black depth markings may detach from the outer sheath of the coaxial dilator introducer component of transcarotid-peripheral access kits.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Obp Medical

    Obp Medical, sold nationwide

    Why: There is a potential for vaginal speculums to contain a burr on the proximal plastic blade, which may introduce a sharp edge in the contact regions for both the patient and the healthcare provider.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Clear Eyes Maximum Itchy Eye Relief

    Prestige Brands Holdings, sold nationwide

    Why: Lack of assurance of sterility. The recall is due to potential contamination

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Gore Viabil Short Wire Biliary Endoprosthesis (2 items)

    W L Gore & Associates, sold nationwide

    Why: 10 mm diameter x 7 cm with transmural drainage holes (VSWVH1006) incorrectly labeled as 10 mm diameter x 10 cm length devices without transmural drainage holes (VSWVN1010).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Bobby Balloon Guide Catheter Ref: Bob-895-Cn Bob-895-Emea Bob-895-Emea-Al B

    Microvention, sold nationwide

    Why: Due to an increase rate of balloon pinhole defects.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Allura Xper Fd. Model Numbers:

    Philips Medical Systems Nederland B.V., sold nationwide

    Why: Firmware issue potentially leading to loss of geometry movements.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Glidesheath Slender A-Kit

    Terumo Medical, sold nationwide

    Why: Product was packaged with the 0.025 guidewire instead of the 0.021 guidewire.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Navify Digital Pathology

    Ventana Medical Systems, sold nationwide

    Why: Due to complaints received for the Image Management System regarding image/metadata discrepancy with the Viewer window

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Thermo Fisher Diagnostics Neisseria Meningitidis Gp C

    Remel Europe, sold nationwide

    Why: Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Erbecryo

    Erbe USA, sold nationwide

    Why: A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the return path, leading to excessive...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Straumann Bone Level Tapered

    Straumann USA, sold nationwide

    Why: Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim may inadvertently contain implants that are 12mm in length instead of 14mm as the labeling would suggest.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Xhibit Central Station

    Spacelabs Healthcare, sold nationwide

    Why: Due to off-the-shelf display port component that has audio/video failures

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    60 in Non-Dehp Minibore Extension Set Res Me2010 Udi-Di Code:

    Bd Switzerland Sarl

    Why: Products may not have received adequate sterilization processing.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Gm Helix Implant

    Straumann USA, sold nationwide

    Why: There may be a mismatch between the implant contained inside the packaging and the information described on the outer carton label. If the the incorrect implant is installed, the issue could cause bone compression or...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Biofire Respiratory Panel

    Biofire Diagnostics, sold nationwide

    Why: Due to increase in false negative results

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Philips Azurion Rystem

    Philips Medical Systems Nederland B.V.

    Why: Two software related issues affecting Azurion R2.2.10 Systems: 1) Potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment and 2) Potential loss of...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Philips Azurion

    Philips Medical Systems Nederland B.V.

    Why: Two software related issues: 1) Potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment and 2) Potential loss of geometry movements that may lead to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Endo-Model

    Waldemar Link Gmbh & Co. Kg (Mfg Site)

    Why: The affected Endo-Model replacement set for a Rotating Hinge tibial plateau incorrectly contains a Pure Hinge plateau. The incorrect plateau could lead to a prolonged or modified surgery as the plateau cannot be...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Pronephro Aki

    Bioporto Diagnostics A/S

    Why: The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Halyard Convenience Kits Containing Recalled Medline Namic Angiographic Star Off (3 items)

    Avid Medical, sold nationwide

    Why: Affected kits contain Medline Namic Angiographic Star Off Handle Manifolds, which were recalled by the manufacturer due to presence of particulates within fluid path of the Manifolds. Particulate within the fluid path...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Drug recall, ongoing

    Dicyclomine Hydrochloride

    Aurobindo Pharma USA, sold nationwide

    Why: shortfill; reports of empty capsules.

    Class II: could cause temporary or reversible harm

    About 940,000 people in the US are prescribed dicyclomine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Drug recall, ongoing

    Cyclophosphamide for Injection (2 products)

    Sunny Pharmtech, sold nationwide

    Why: Presence of Particulate Matter; identified as stainless steel

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Drug recall, ongoing

    Mirabegron

    Zydus Pharmaceuticals (USA), sold nationwide

    Why: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

    Class II: could cause temporary or reversible harm

    About 700,000 people in the US are prescribed mirabegron each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Stryker Ahto Dual Spike Tube Set Packaging and Stryker Ahto Tube Set Packaging and 2 more (5 items)

    Stryker, sold nationwide

    Why: There has been an increased amount in reported complaints consistently describing leaking from the handpiece during use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Q6 Edge and Quantum Outback and 5 more (13 items)

    Pride Mobility Products, sold nationwide

    Why: If the "Remind Me Later" option is selected for user reminders, reminder pop-up messages may appear while the wheelchair is in use. If this occurs while driving the wheelchair, the wheelchair may perform an unexpected...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Infinion Cx Lead Kit

    Boston Scientific Neuromodulation

    Why: Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Charger for the Therabody Theragun

    Therabody, sold nationwide

    Why: Charging cradle for the device may overheat while charging the device's removable battery pack, presenting risk of thermal event (fire). Firm has received reports alleging the product caught fire and other reports...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Radial Jaw (3 items)

    Boston Scientific, sold nationwide

    Why: Potential for breach in sterile barrier of device packaging.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Coaptium Connect (8 items)

    Tissium Sa, sold nationwide

    Why: Currently labeled shelf life of 36 months is not substantiated by real-time data. Devices will be relabeled to reflect revised shelf life of 26 months. The use of a medical device beyond its validated shelf life may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Flow Anesthesia Machine Flow-I C20

    Maquet Critical Care Ab, sold nationwide

    Why: Events observed where anesthetic agent was not delivered when the vaporizer was activated. Failure to deliver the anesthetic agent may result in the patient receiving insufficient anesthesia and may lead to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Femoral Valgus Adaptor and Psa Box Trial and 2 more (4 items)

    United Orthopedic, sold nationwide

    Why: Due to an incomplete process of the component screw by a subcontractor which prevents the properly assembling of stem trail.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Atellica Ch Urine Albumin Ref:

    Siemens Healthcare Diagnostics, sold nationwide

    Why: Processing of urine albumin assay on the CI analyzers may lead to the following issues: Falsely depressed Atellica CH Urea Nitrogen (UN_c) results; Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Mc2 Portable X-Ray System

    Oxos Medical, sold nationwide

    Why: Due to a defective circuit board that overheats

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Forward Oral Airway Kit and Kingfisher Compact Individual First Aid Kit. Ref Number: (2 items)

    Integrated Medcraft, sold nationwide

    Why: Devices could potentially contain an occluded or partially occluded Guedel Airway tip.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Ge Healthcare Mac Vu360

    Ge Medical Systems Information Technologies, sold nationwide

    Why: Software issue issue with the MAC VU360 v3.0 system. After selecting the order refresh icon, an open preview or review screen might fail to close automatically after 2 minutes of inactivity. As a result, data from a...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Ref # D23354 and Ref # D23352 (2 items)

    Beckman Coulter, sold nationwide

    Why: Analyzers contain incorrect algorithms which may affect antimicrobial susceptibility test results, leading to false susceptibility classifications."

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Blom-Singer Classic Indwelling Voice Prosthesis (2 items)

    Freudenberg Medical, sold nationwide

    Why: Incorrect labeling- The labeled box for the Large Esophageal Flange contains a Large Esophageal and Tracheal Flange, and the labeled box for the Large Esophageal and Tracheal Flange contains a Large Esophageal Flange.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Femoral Offset Bushing (2 items)

    United Orthopedic, sold nationwide

    Why: Due to a design issue causing the incorrect engraved numbering on implant that could result in the incorrect orientation of the implant.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Happiest Baby

    Happiest Baby, sold nationwide

    Why: This recall is retroactively being reported. Refurbished bassinets failed to meet quality standards prior to distribution.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Wasplab

    Copan Wasp, sold nationwide

    Why: Due to a software issue within the WebApp that potentially prevents the user to overwrite the results.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    5-Plasma Bivalirudin Amr Verification Kit and 5-Plasma Bivalirudin Calibrator and 1 more (3 items)

    Aniara Diagnostica, sold nationwide

    Why: Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Gem Premier (2 items)

    Instrumentation Laboratory, sold nationwide

    Why: The active ingredient concentration in the lysing bag solution of specific GEM Premier 5000 lots did not meet established manufacturing specifications. The malfunction could result in delayed recognition and management...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Anti-Torque

    Innovasis, sold nationwide

    Why: Pedicle screw system intended to provide immobilization/stabilization of spinal segments as adjunct to thoracic/lumbar/sacral spine fusion may have anti-torque instrument with undersized condition which could prevent...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Nerivio Infinity. Model/Catalog Number: Fgd000100. Software Version: Fw Versio

    Theranica Bioelectronics

    Why: Potential for the batter to have a thermal-runway event during charging, resulting in smoke and odor.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Ge Healthcare Portrait Core Services Sw V

    Ge Medical Systems Information Technologies, sold nationwide

    Why: A software vulnerability may allow unauthorized persons to gain privileged access to the device, which could result in loss of patient monitoring, missed patient alarms, and/or access to Protected Health Information...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Intramedullary Bone Saw Blade Assembly Model/Catalog Number: (5 items)

    Biomet

    Why: Zimmer Biomet is conducting a medical device recall removal for various sizes of the Intramedullary Bone Saw Blade Assembly due to potential sterile barrier packaging damage caused by an exposed saw blade.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Munevo Drive and Munevo Drive R-Net Powered Wheelchair Hands-Free Control App

    Munevo Gmbh, sold nationwide

    Why: A software issue may cause the wheelchair's driving mechanism to fall out of calibration. When this occurs, the device may experience unexpected steering drift or imprecise control while driving the wheelchair. The...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Merge Pacs and Merge Orthopacs (2 items)

    Merge Healthcare, sold nationwide

    Why: Thumbnails from a previously opened patient study may be displayed in the Thumbnail Bar while a different patient study is currently open.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Filmarray Ngds Warrior Panel Ref Ngds-Asy-0007 Udi-Di Code:

    Biofire Defense, sold nationwide

    Why: Firm has identified mismatches between the outbreak strain and the reference strain used in the development of its qualitative, multiplexed, nucleic acid-based in vitro diagnostic panel test.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Hardydisk Ast Cefiderocol

    Hardy Diagnostics, sold nationwide

    Why: Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Dialysis Change Tray Clear Sequence

    Medical Action Industries, Inc. 306, sold nationwide

    Why: Convenience kits contain needle free access device that has an improper seal which may result in doming or tearing of the silicone seal.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Dash Rapid Pcr Instrument

    Nuclein, sold nationwide

    Why: Due to a software issue which may result in false co-infection (e.g., Positive for Flu A, when SARS-CoV-2 is present).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Philips Allura and Philips Azurion Under the Following System Descriptions and Corresponding Model and 1 more (3 items)

    Philips Medical Systems Nederland B.V., sold nationwide

    Why: Potential Loss of imaging functionality, loss of motorized movement, or loss of data due to unauthorized Hard Disk Drives.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Neuroguard Iep

    Contego Medical, sold nationwide

    Why: Carotid stent and post-dilation balloon system with integrated embolic protection system has an integrated filter, that due to a wire-to-filter-bond issue, may fail to open following sheath retraction; and if this...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Remisol Advance with Software Version

    Beckman Coulter Biomedical Gmbh

    Why: Due to software issues where does not handle combo assay results. The software may replace the final combo test result with one of the sub-results resulting in incorrect reporting of test outcomes.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Smn

    Siemens Healthcare Diagnostics, sold nationwide

    Why: out-of-specification sodium azide concentration in Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Lot U2. While the assay results were not impacted, the overall health risk to lab technicians due to...

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Device recall, ongoing

    Syva Emit Disopyramide Assay Enzyme Immunoassay

    Siemens Healthcare Diagnostics, sold nationwide

    Why: Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is...

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 12, 2026

    Drug recall, ongoing

    Total Parental Nutrition - Pediatric Pn Patient-Specific Tpn Bag

    Central Admixture Pharmacy Services

    Why: Incorrect Product Formulation

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Resmed Astral

    Resmed, sold nationwide

    Why: Due to a Supercapacitor electrolyte leakage on Printed Circuit Board Assembly (PCBA) may damage the charger chip, causing fail-safe state and interruption of ventilation therapy.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Drug recall, ongoing

    Mycophenolate Mofetil

    Mylan Pharmaceuticals, sold nationwide

    Why: Presence of precipitate

    Class II: could cause temporary or reversible harm

    About 160,000 people in the US are prescribed mycophenolate mofetil each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Drug recall, ongoing

    Dorzolamide Hydrochloride and Timolol Maleate

    Micro Labs USA, sold nationwide

    Why: Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.

    Class II: could cause temporary or reversible harm

    About 980,000 people in the US are prescribed timolol each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Stryker Hoffmann Ii Connecting Rod Micro (7 items)

    Stryker Gmbh, sold nationwide

    Why: Potential cracking of the Hoffmann II Carbon Connecting Rods following cleaning and sterilization.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Eopa Elongated One-Piece Arterial Cannula Dil Tip and Eopa and 1 more (6 items)

    Medtronic Perfusion Systems, sold nationwide

    Why: Pinhole leaks may occur in the wire-wound body during cardiopulmonary bypass. Potential risks associated with this condition may include hypovolemia, vessel laceration or perforation, hypotension, ischemia, and organ...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Pack Angiography Ncmc

    Medical Action Industries, Inc. 306

    Why: Cardiovascular procedure kits contain manifolds, the subject of another recall, that may have particulate within the fluid path, which has the potential to be introduced into blood circulation and become lodged within...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Ams Aligned Medical Solutions Medical Convenience Kits Labeled As: and Ams Aligned Medical Solutions Medical Convenience Kits Labeled As: Port Tray - and 4 more (8 items)

    Windstone Medical Packaging, sold nationwide

    Why: Windstone Medical Packaging recalled specific items and lots of AMS convenience kits containing Elevaris Lidocaine HCl injection USP. Elevaris Medical Devices Inc. recalled the Lidocaine HCl injection USP due to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Gem Premier (6 items)

    Instrumentation Laboratory, sold nationwide

    Why: Potential for Bar Code Reader (BCR) wands, used with the GEM Premier 5000 and GEM Premier 7000 systems, to assign patient results to an incorrect patient ID.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Drug recall, ongoing

    Azelaic Acid

    Glenmark Pharmaceuticals Inc., USA, sold nationwide

    Why: CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Ams Aligned Medical Solutions Medical Convenience Kits Labeled As: (4 items)

    Windstone Medical Packaging, sold nationwide

    Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Osteoballast

    Isotis Orthobiologics, sold nationwide

    Why: Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc DBM (fill for 45 ¿ 11 mm...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Power Over Fiber Base Module

    Terex Utilities, sold nationwide

    Why: Device not certified - no laser product report was filed with CDRH prior to distribution. Product label incorrectly states device is "Class IV", although Class 1 is appropriate for device. Improperly labeled - omitted...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Iqon Spectral Ct Iqon Spectral Ct Upgrades and Brilliance Ict Brilliance Ict Upgrades Brilliance Ict Sp Brilliance Ct and 1 more (3 items)

    Philips Medical Systems, sold nationwide

    Why: The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    Permobil M3 Corpus Power Wheelchair with Heavy Duty Shock Ref:120031

    Permobil, sold nationwide

    Why: This recall has been reported retroactively. The power wheelchair firmware lacks a speed restriction to maintain stability when the seat lift exceeds 50 mm, which may cause the user to fall from the wheelchair or the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    M5 Corpus Power Wheelchair Ref

    Permobil, sold nationwide

    Why: This recall is being reported retroactively. Power Platform firmware is missing specific drive inhibit logic. This issue may allow the chair to drive under restricted conditions, and may create an unstable condition in...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Device recall, ongoing

    L-Cath Midline S/L Catheter and L-Cath Picc S/L Peripherally Inserted Central Catheter: (2 items)

    Argon Medical Devices

    Why: Catheters, indicated for short/long-term peripheral access to central venous system for the administration of fluids, medications, nutrients; and sampling, may experience leaking and/or cracking at the hub, which may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 5, 2026

    Drug recall, ongoing

    Dabigatran Etexilate (3 products)

    Ascend Laboratories, sold nationwide

    Why: Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Levothyroxine Sodium (12 products)

    Major Pharmaceuticals, sold nationwide

    Major Pharmaceuticals recalled levothyroxine tablets, 75, 88 and 150 mcg, in 10- and 100-tablet blister cartons after tests found less active ingredient than labeled. Lots N02172A and N02288A and other lots, expiring 07/2026 to 01/2027, were distributed nationwide in the USA.

    FDA reason: Subpotent Drug

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Cetirizine Hydrochloride

    Jb Chemicals and Pharmaceuticals, sold nationwide

    Why: Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

    Class I: could cause serious harm or death

    About 4.1 million people in the US are prescribed cetirizine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Ropivacaine Hydrochloride and Lidocaine Hydrochloride,Epinephrine Bitartrate and 2 more (5 products)

    Fresenius Kabi USA, sold nationwide

    Why: Presence of Particulate Matter: Hair was found in products

    Class II: could cause temporary or reversible harm

    About 1.1 million people in the US are prescribed epinephrine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Amlodipine and Olmesartan Medoxomil

    Ascend Laboratories, sold nationwide

    Why: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

    Class II: could cause temporary or reversible harm

    About 18.4 million people in the US are prescribed amlodipine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Cyproheptadine Hydrochloride

    Rising Pharma Holding, sold nationwide

    Why: Presence of Precipitate: medication was crystallizing and particles floating in the bottle

    Class II: could cause temporary or reversible harm

    About 220,000 people in the US are prescribed cyproheptadine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Naphazoline Hydrochloride, Polysorbate 80 and Hypromellose, Tetrahydrozoline Hydrochloride and 3 more (8 products)

    Rohto-Mentholatum (Vietnam) Co., sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Trokendi XR

    Supernus Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications

    Class III: unlikely to cause harm

    About 2 million people in the US are prescribed topiramate each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Glycopyrrolate

    Precision Dose, sold nationwide

    Why: Failed Impurities/Degradation Specifications

    Class II: could cause temporary or reversible harm

    About 450,000 people in the US are prescribed glycopyrrolate each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Faradrive Steerable Sheath Clear and Faradrive Steerable Sheath Clear Ous and 2 more (4 items)

    Boston Scientific, sold nationwide

    Why: Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Medline Medical Procedure Convenience Kit Labeled As: and Medline Medical Procedure Convenience Kit Labeled As: Hip Cds-Lf (2 items)

    Medline Industries

    Why: The procedure kits contain ICU Medical, Inc. pain management kits containing Bupivacaine Hydrochloride in Dextrose Injection, USP, which were recalled due to quality issues that could result in drug ineffectiveness.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Medline Anterior Hip and Medline Convenience Kits Labeled As: (3 items)

    Medline Industries

    Why: Medline Industries, LP is issuing a recall for specific Medline kits containing B. Braun convenience kits that include Bupivacaine Hydrochloride in Dextrose Injection, USP. B. Braun Medical Inc. was notified by their...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Hotline Fluid Warming Set

    Icu Medical, sold nationwide

    Why: ICU Medical became aware of an increased likelihood of leakage in specific Lots of L-70 HOTLINE Fluid Warming Sets due to potentially inadequate solvent application at the tubing to return connector bond.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Medline Convenience Kits Containing Bard¿ Silastic¿ Foley Catheters (9 items)

    Medline Industries, sold nationwide

    Why: Affected kits contain recalled Bard Silastic Foley Catheters. Catheters were recalled by manufacturer due to increased amount of raw material present on the surface of the catheter. Issue may result in the use of...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Divalproex Sodium

    Bionpharma, sold nationwide

    Why: Presence of Foreign Tablets/Capsules

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Lidocaine, Kenalog, Povidone Iodine

    Asclemed USA

    Why: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

    Class III: unlikely to cause harm

    About 610,000 people in the US are prescribed lidocaine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Halyard Standard Line Insertion Pack. Model/Catalog Number: Pvhm234-01. Conv

    Avid Medical, sold nationwide

    Why: Defects in the silicone seal, which may result in "doming" of the silicone seal due to improper sealing, potentially leading to fluid occlusion or leakage.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Penumbra System Red

    Penumbra, sold nationwide

    Why: Due to manufacturing issues, reperfusion catheters may fractures

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Safeop Patient Interface

    Alphatec Spine, sold nationwide

    Why: Intraoperative neuromonitoring device, due to a software issue, may experience loss or interruption of triggered electromyography (tEMG) functionality during use, displaying as system faults, loss of communication...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Minimed Go App

    Medtronic Minimed, sold nationwide

    Why: For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Flexible Hystero-Fiberscope Kits Ref:

    Karl Storz Endoscopy, sold nationwide

    Why: Flexible hysteroscopes indicated for use during diagnostic and operative hysteroscopic procedures may contain an expired single use endoscopic seal for gynecology use, which could impact the assurance of sterility.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Power F2 Powered Fastening System

    Ferno-Washington, sold nationwide

    Why: Product may experience accelerated roller wear and potential deformation due to interference between the roller assembly and rail. In the worst-case condition, rail mechanism may become lodged during operation and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Ventriculostomy Kit

    Medtronic Neurosurgery, sold nationwide

    Why: Ventriculostomy devices, used during ventriculostomy procedures to gain access to the ventricular system, may exhibit endotoxin levels that exceed the acceptable limit for devices that come into contact with...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Pipeline Flex Embolization Device with Shield Technology (2 items)

    Micro Therapeutics, sold nationwide

    Why: Incorrect labeling - embolization devices labeled as 3.0 mm x 20 mm implants contain 12 mm implants, and devices labeled as 3.0 mm x 12 mm implants contain 20 mm implants.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    P28 Phanton Intramedullary Nail System

    Paragon 28, sold nationwide

    Why: Paragon 28 received two (2) complaints were received involving breaches in the sterile barrier of the pouch packaging.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    the Intended Use Is To Be Paired with A Weapon for Aiming Purposes.

    Wilcox Industries, sold nationwide

    Why: Wilcox is notifying all customers who have purchased a product from the BOSS Xe family that a software enhancement to increase safety has been released and all units should be returned to implement this change.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Halyard Eye Pack. Model/Catalog Number: Lvey27 Convenience Kit.

    Avid Medical, sold nationwide

    Why: Incorrect concentration of Betadine solution contained within certain AVID convenience kits.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Snapshotglo Wound Imaging Device

    Kent Imaging, sold nationwide

    Why: The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Olympus High Flow Insufflation Unit - Uhi-4. Model Number: Uhi-4

    Olympus Corporation of the Americas, sold nationwide

    Why: Potential for unexpected instances where the front panel display turns off unexpectedly, and air delivery (insufflation) ceases.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Boston Scientific Therasphere

    Boston Scientific, sold nationwide

    Why: Software anomaly occurs when a user adds one or more vials to the cart and subsequently returns to the Activity Calculator to modify one or more input. When a user modifies an input and selects "Recalculate", the dose...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Emano Flow with Software Version V2.0.0 Gs1 Gtin Code:

    Emano Metrics, sold nationwide

    Why: Problem description/Reason for recall: During the period March 22, 2026, to May 29, 2026, recorded urination audio was captured at 48,000 Hz while the model was trained and validated on 44,100 Hz audio. The models...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Seaspine Polyaxial Head Ref Number:

    Seaspine Orthopedics, sold nationwide

    Why: Due to manufacturing error, polyaxial head may popoff from the screw intraoperatively following insertion.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    3mensio Workstation

    Pie Medical Imaging B.V., sold nationwide

    Why: User measurement value reported by diagnostic bioimaging software intended to measure/visualize cardiovascular structures may be larger (0.8% to 34.4%) than the actual anatomical dimension, if all the following occur...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Silent Nite Sleep Appliance

    Prismatik Dentalcraft, sold nationwide

    Why: Due to device not having FDA Clearance

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Olympus

    Olympus Corporation of the Americas, sold nationwide

    Why: Potential for the HDMI and DisplayPort (DP) connectors can become faulty resulting in image loss or image abnormalities.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Farastar Ablation Generator Eu

    Boston Scientific

    Why: Boston Scientific is replacing specific FARASTAR PFA generators which have a configuration that is not compatible for use with the FARAPOINT PFA catheter.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Farastar Ablation Generator Eu and Farastar Pulsed Field Ablation Generator and 1 more (3 items)

    Boston Scientific

    Why: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Device recall, ongoing

    Medline Medical Convenience Kits Labeled As: and Medline Medical Convenience Kits Labeled As: Neuro Pack (4 items)

    Medline Industries

    Why: Medline Industries, LP is issuing a recall for specific Medline convenience kits containing BD PurPrep 26 mL which may be contaminated with low levels of Bacillus species.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 29, 2026

    Drug recall, ongoing

    Dabigatran Etexilate (2 products)

    Ascend Laboratories, sold nationwide

    Why: Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Abiomed Impella Cp Set and Abiomed Impella Cp Introducer Kit and 6 more (13 items)

    Abiomed, sold nationwide

    Why: A potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These manufacturing issues are not visually detectable by the user, and 14Fr or...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Drug recall, ongoing

    Chlorhexidine Gluconate and Isopropyl Alcohol

    Carefusion 213, sold nationwide

    Why: Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator

    Class II: could cause temporary or reversible harm

    About 960,000 people in the US are prescribed chlorhexidine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Drug recall, ongoing

    Nystatin

    Padagis US, sold nationwide

    Why: Subpotent Drug: Low out of specification assay results performed during long-term stability testing.

    Class II: could cause temporary or reversible harm

    About 1.2 million people in the US are prescribed nystatin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    General Biospy Tray and Arterial Line Kit and 4 more (6 items)

    Argon Medical Devices, sold nationwide

    Why: Kits containing Lidocaine HCL Injection USP 1% 10mg/mL 5mL ampules subject to another recall recalled due to not meeting release criteria for sterility.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Drug recall, ongoing

    Carbamide Peroxide and Foster & Thrive (11 products)

    Bell Pharmaceuticals, sold nationwide

    Why: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Abiomed Ref: (3 items)

    Oscor

    Why: Due to manufacturing issues, there is a potential for the 14Fr and 23Fr introducer sheaths to leak from the sidearm, under the sheath cap, and along the hub score lines in the hub region.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Rapid Refill Continuous Injection System

    Boston Scientific, sold nationwide

    Why: Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Drug recall, ongoing

    Clevipidine

    Chiesi USA, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Papablic Replacement Brush Heads. Model Number: Papa317aa. and Papablic Replacement Brush Heads. Model Number: Papablic18b (2 items)

    Papablic, sold nationwide

    Why: Potential for brush heads to break.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Icu Medical Plum Duo Infusion Pump and Icu Medical Plum Solo Precision IV Pump (2 items)

    Icu Medical, sold nationwide

    Why: In a specific scenario, the pump will not decrement the Volume to be Infused (VTBI) displayed on the Delivery screen and may deliver up to twice the VTBI at the programmed rate.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Da Vinci Sp Instrument Arm Drape

    Intuitive Surgical, sold nationwide

    Why: Robotic-assisted surgical system arm drapes may detach from the instrument arm due to an issue involving the drape rings located at the top of the product, which may expose a section of instrument arm, which may result...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Photera (3 items)

    Daavlin Distributing, sold nationwide

    Why: Calibrated Output was not calculating correctly - UV Sensor GAIN being applied was incorrect - GAIN seemed to be "4/5" instead of "7" (counts were at ~1000 instead of ~5000).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Optima Xr200amx and Optima Xr220amx and 1 more (3 items)

    Ge Medical Systems, sold nationwide

    Why: GE HealthCare has become aware that in certain Optima XR200/220/240amx systems that have had a column replacement completed, functional testing of the safety pawl may not have been performed to confirm proper assembly....

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Olympus Ellik Evacuator Includes Glass Body and Olympus Toomey Evacuator and 1 more (4 items)

    Olympus Corporation of the Americas, sold nationwide

    Why: Some sterilization parameters included in the IFU may not consistently render the devices adequately sterile and therefore should no longer be used to sterilize the devices.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    St Aia-Pack Testosterone

    Tosoh Bioscience, sold nationwide

    Why: The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Medline Kits Containing Zimmer Biomet Mixing Bowls and Spatulas Total Knee Pa (2 items)

    Medline Industries, sold nationwide

    Why: Kits contain Zimmer Biomet mixing bowls and spatulas, which were recalled due to seal nonconformities which present risk of sterility breach. Health consequences from use of product include clinically insignificant...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Medtronic Bio-Medicus Adult Cannula Kit and Medtronic Dlp One-Piece Pediatric Arterial Cannula (2 items)

    Medtronic Perfusion Systems, sold nationwide

    Why: Medtronic received two complaints of loose foreign material confirmed as containing trace levels of blood.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    the Vasoview Hemopro

    Maquet Cardiovascular, sold nationwide

    Why: Getinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-28782A) performed by STERIS at its...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Rio" Ii Nasal Pillows Interface

    3b Medical, sold nationwide

    Why: Packaging and labeling discrepancy involving product size identification and associated Unique Device Identifier (UDI/GTIN).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 22, 2026

    Device recall, ongoing

    Orthofix Minirail and Orthofix Articulated Minirail Fixator Horizontal Axis Ref: M111 (4 items)

    Orthofix U.S.

    Why: Unilateral external fixation devices may be incorrectly labeled. Minirail M101 was labeled as M103, Minirail M103 was labeled as M101, and Minirail M122 was labeled as M111

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Drug recall, ongoing

    Medline Remedy Specialized Silicone Cream

    Biomed Laboratories, sold nationwide

    Why: Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Olympus Single Use Distal Cover

    Olympus Corporation of the Americas, sold nationwide

    Why: Olympus has developed and released newly designed version of the Distal Cover (MAJ-2315) to replace previous design of the Single Use Distal Covers.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    5008x Blood Tubing Set

    Fresenius Medical Care Holdings, sold nationwide

    Why: Potential for Online Port Errors due to connection issues when connecting the SafeLine of the 5008X CAREset to the substitution fluid port of the 5008X CAREsystem.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Drug recall, ongoing

    Gasco Isopropyl Alcohol and Drogueria San Juan Puerto Rico Isopropyl Alcohol (6 products)

    Gasco Industrial, sold nationwide

    Why: Subpotent drug

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Drug recall, ongoing

    Pemetrexed for Injection and Bortezomib for Injection and 1 more (4 products)

    Reliance Life Sciences Private Limited, sold nationwide

    Why: Lack of Sterility Assurance

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Atellica Ch Enzymatic Hemoglobin A1c

    Siemens Healthcare Diagnostics, sold nationwide

    Why: The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Intracept Access Instruments

    Boston Scientific Neuromodulation, sold nationwide

    Why: Intraosseous nerve ablation system instruments may have sterile barrier breach of the outer tray seal, which may introduce a risk of sterility breach, and if breached could lead to severe infection.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Drug recall, ongoing

    Methohexital Sodium

    Onesource Specialty Pharma Limited, sold nationwide

    Why: Failed Impurities/Degradation Specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Drug recall, ongoing

    Methohexital Sodium

    Quva Pharma, sold nationwide

    Why: Failed Impurities/Degradation Specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Aquacel AG Surgical Sp Ref:

    Convatec, sold nationwide

    Why: Surgical dressing manufactured out of specification (greater thickness).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Gsp Neonatal Galt Kit. Product Codes:

    Wallac Oy, sold nationwide

    Why: Reduction in the on-board stability of the GSP GALT assay. This may increase the likelihood of run-QC failures and consequently delay the reporting of patient results.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Kl Owen Custom Orthodontic Solution

    Klowen Braces, sold nationwide

    Why: A product error defect may cause incorrect bracket placement.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Vesius Surgeon Console US

    Cmr Surgical Limited, sold nationwide

    Why: Secure Boot was mistakenly not enabled at manufacturing time, which presents a potential cybersecurity risk.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Medline Convenience Kits: (3 items)

    Medline Industries, sold nationwide

    Why: Convenience Kits contain Covidien Mon-a-Therm General Purpose Temperature Probes Size 9 Fr. Medtronic has issued a recall of specific production lots of the Covidien Mon-a-Therm general purpose temperature probe-size 9...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Fletcher Ct/Mr Shielded Applicator Set Product Name: Intracavitary Remote After and Brachytherapy Applicator Product Name: Advanced Gynecological Applicator Produ and 1 more (3 items)

    Elekta, sold nationwide

    Why: Due to safety concerns regarding the detachment of the tip of the intrauterine tube (IU tube) that may remain within a patient.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Tmini Femur Tracking Array Ref

    Think Surgical, sold nationwide

    Why: Due to manufacturing/design issue where the knob on the tracking array may loosen causing potential misalignment of the array.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Vitek

    Biomerieux

    Why: Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Omnitract Surgical Retractor System

    Integra Lifesciences Corp. (Neurosciences), sold nationwide

    Why: The current Omni-Tract Surgical Retractor System IFU states a dry time of 30 minutes. Integra LifeSciences has identified that the dry time needs to be extended to 90 minutes, 110 minutes, or 120 minutes depending on...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Drug recall, ongoing

    Clomiphene Citrate USP Active Pharmaceutical Ingredient

    Shimoga Chemicals

    Why: cGMP deviations

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Minimed

    Medtronic Minimed

    Why: A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 15, 2026

    Device recall, ongoing

    Empowr (2 items)

    Encore Medical

    Why: Due to packaging discrepancy with incorrect product size mixed up.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Chlorhexidine Gluconate and Isopropyl Alcohol and Povidone Iodine and Isopropyl Alcohol (10 products)

    Carefusion 213, sold nationwide

    Why: Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

    Class II: could cause temporary or reversible harm

    About 960,000 people in the US are prescribed chlorhexidine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Levothyroxine Sodium

    Accord Healthcare, sold nationwide

    Why: Subpotent Drug

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Prednisolone Acetate

    Lupin Pharmaceuticals, sold nationwide

    Why: Presence of Foreign Substance

    Class II: could cause temporary or reversible harm

    About 2.9 million people in the US are prescribed prednisolone each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Undecylenic Acid and Fungal Fusion Eradication Solution and 3 more (8 products)

    Blaine Labs, sold nationwide

    Why: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate

    Lannett Company, sold nationwide

    Why: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

    Class II: could cause temporary or reversible harm

    About 5.3 million people in the US are prescribed dextroamphetamine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Omnipod and Omnipod Dash Pod. Includes the Below Model/Ref Numbers: (3 items)

    Insulet, sold nationwide

    Why: External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Synjardy XR Tablets

    Boehringer Ingelheim Pharmaceuticals

    Why: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

    Class II: could cause temporary or reversible harm

    About 19.6 million people in the US are prescribed metformin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Hillrom Volara System P.Circuit Kit Ac and Hillrom Volara System P.Circuit and 2 more (4 items)

    Baxter Healthcare, sold nationwide

    Why: There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the patient and ineffective nebulization...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Breathing Circuit Set

    Hamilton Medical AG, sold nationwide

    Why: Ventilator coaxial breathing circuit may have, expiratory valve sets with membranes sticking to valve body, not detectable during pre-operative test, which will result in "exhalation obstructed " alarm, which may result...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Lidocaine Hydrochloride and Lidocaine Hydrochloride Anhydrous (2 products)

    Asclemed USA, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    About 610,000 people in the US are prescribed lidocaine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Ck000495a Poly Midline Catheter and 5855240 Power-Trialysis Slim-Cath Straight Short-Term Dialysis Catheter and 12 more (14 items)

    Bard Access Systems, sold nationwide

    Why: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Cre Pro Wireguided and Cre Wireguided (12 items)

    Boston Scientific, sold nationwide

    Why: Potential sterile breach of the pouches in which devices are packaged.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    A M S (4 items)

    Windstone Medical Packaging, sold nationwide

    Why: Kits contain Webcol Large Alcohol Prep Pad which were recalled by Cardinal Health following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Medtronic Harmony Delivery Catheter System

    Medtronic Heart Valves Division, sold nationwide

    Why: Devices containing inner shaft assemblies from specific manufacturing lots may have an increased potential for distal tip detachment from the delivery system under certain procedural or anatomical conditions due to a...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Reprocessed Electrophysiology Catheters and Ultrasound Catheters Item No.

    Medline Industries, sold nationwide

    Why: Expansion of RES 98277. Specific lots of reprocessed catheters may contain small particles of residual material. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Medline Convenience Kits Containing Recalled Swan-Ganz Catheters Kit Germanto and Medline Convenience Kits Containing Recalled Swan-Ganz Catheters Cardiac Majo and 5 more (8 items)

    Medline Industries, sold nationwide

    Why: Kits contain Swan-Ganz catheters recalled by Becton Dickinson (BD). BD has received complaints of leaks/breakage involving failures of the (blue) proximal injectate lumen hub on these catheters. This has led to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Pilling Wecksorb Neurosponges

    Teleflex, sold nationwide

    Why: Due to out-of-specification, or potential out-of-specification, levels of endotoxins

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Medline Convenience Kits: (15 items)

    Medline Industries, sold nationwide

    Why: The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Covidien Shiley Disposable Decannulation Plug Ref Ddcp Udi-Di Code:

    Covidien, sold nationwide

    Why: Due to product labeling incorrectly including the symbol indicating non-DEHP (Bis(2-ethylhexyl) phthalate as the product includes 30 to 35% DEHP.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Glucagon

    Lupin Pharmaceuticals, sold nationwide

    Why: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Cinacalcet (3 products)

    Cipla USA, sold nationwide

    Why: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Fexofenadine Hydrochloride Tablets

    Sun Pharmaceutical Industries, sold nationwide

    Why: Failed Impurities/Degradation Specifications

    Class III: unlikely to cause harm

    About 680,000 people in the US are prescribed fexofenadine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    A.T.S¿ (2 items)

    Zimmer Surgical, sold nationwide

    Why: Potential sterility breach in sealing area of sterile pouch. If used, issue may result in moderate localized infection. If discovered prior to use, may result in clinically insignificant extension of surgery to find...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Ustekinumab-Srlf

    Accord Biopharma, sold nationwide

    Why: Lack of assurance of Sterility:

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Drug recall, ongoing

    Gemcitabine

    Mckesson, sold nationwide

    Why: Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Gc Agar Base

    Remel, sold nationwide

    Why: Reduced or no recovery of some strains of Neisseria gonorrhoeae.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Raycare (2 items)

    Raysearch Laboratories Ab, sold nationwide

    Why: Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Radius Vsm Ecg Pre-Connected Set and Radius Vsm Disposable Nibp Cuff (2 items)

    Masimo, sold nationwide

    Why: Two devices recalled: 1) Electrocardiogram (ECG) electrode assembly ECG feature may incorrectly detect extreme bradycardia, tachycardia and trigger alarms on normal heart rate patients, which may distract clinicians...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Zeiss Intrabeam Spherical Applicator

    Carl Zeiss Meditec AG, sold nationwide

    Why: Spherical applicators (radiation therapy accessory) failed to meet manufacturing specifications.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Artis Icono Ceiling. Model Number:

    Siemens Medical Solutions USA, sold nationwide

    Why: Potential issue with the Display ceiling suspension (DCS Fix XL) that holds the monitor in place. Over time some screws that keep the monitor attached to the suspension may gradually loosen.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Enfit Exset Strl

    Medela

    Why: May contain incorrect connectors and will not attach or misconnect to ENFit connections and is thus incompatible. Issue could lead to slight delay in delivery of enteral nutritional fluids or oral medication.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Gore¿ Tag¿ Thoracic Branch Endoprosthesis Side Branch Component Catalog Numbers

    W L Gore & Associates, sold nationwide

    Why: Due to catheter separation

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Cyberknife Treatment Deliver System Equipped with the Xchange Robotic Collimator

    Accuray Incorporated, sold nationwide

    Why: In certain cases, a collimator may not fully dock, which triggers a system interlock and prevents motion from the operator console. If personnel then enter the treatment room and initiate motion using the in-room...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Adapter for Head Positioning

    Baxter Healthcare, sold nationwide

    Why: The Adapter for Head Positioning accessory may become loose during patient positioning and unintentionally move when used in conjunction with the side rails of the Upper Back Section H V U component on Baxter operating...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Artis Icono Floor. Model Number: and Artis Icono Biplane. Model Number: and 1 more (3 items)

    Siemens Medical Solutions USA, sold nationwide

    Why: Potential for loss of movement capability after adjusting the detector lift height to its maximum or minimum limits.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Cyberknife Treatment Deliver System Equipped with the Xchange Robotic Collimator

    Accuray Incorporated, sold nationwide

    Why: In certain cases, a collimator may not fully dock, which triggers a system interlock and prevents motion from the operator console. If personnel then enter the treatment room and initiate motion using the in-room...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Solar Gi System

    Laborie Medical Technologies, sold nationwide

    Why: Under extended clinical use conditions (e.g., long duration studies), moisture generated within the pneumatic circuit may accumulate inside the system's internal tubing or at the hydrophobic filter and waterproof...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Short Monobloc Stem Broaches

    Medacta USA, sold nationwide

    Why: Surgical instruments used during shoulder arthroplasty procedures does not progressively translate to replicate implant geometry, so the reaming guide and the stem reamer are positioned approximately 0.2 mm per size...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Intellicuff

    Hamilton Medical AG, sold nationwide

    Why: Due to reported complaints, the cuff device may alarm with a "Cuff System Leakage" error. As a result, the motor may pump continuously and fail to maintain the cuff pressure set by the user.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Syringe Luer Lok

    Mentor Texas

    Why: A single lot of expired syringes were distributed due to a distribution system control failure.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Depuy Synthes (2 items)

    Depuy (Ireland)

    Why: The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • July 8, 2026

    Device recall, ongoing

    Medline

    Bd Switzerland Sarl

    Why: Due to engineering sample labeled "Not for Human Use" being inadvertently shipped it the U.S. market.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)

Current drug shortages

69 drugs

DrugStatusUpdatedReasonCategory
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Current Oct. 2, 2026 Other Psychiatry
Azacitidine Injection Current Oct. 2, 2026 Other Oncology
Clonazepam Tablet Current Oct. 2, 2026 Other Neurology, Pediatric, Psychiatry
Dexmedetomidine Hydrochloride Injection Current Oct. 2, 2026 Other Anesthesia
Lisdexamfetamine Dimesylate Capsule Current Oct. 2, 2026 Shortage of an active ingredient Psychiatry
Methylprednisolone Acetate Injection Current Oct. 2, 2026 Other Rheumatology
Amino Acid Injection Current Oct. 1, 2026 Shortage of an active ingredient Gastroenterology
Atropine Sulfate Injection Current Oct. 1, 2026 Discontinuation of the manufacture of the drug Anesthesia, Neurology, Pediatric
Carboplatin Injection Current Oct. 1, 2026 Discontinuation of the manufacture of the drug Oncology
Dextrose Monohydrate 10% Injection Current Oct. 1, 2026 Discontinuation of the manufacture of the drug Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Dextrose Monohydrate 5% Injection Current Oct. 1, 2026 Demand increase for the drug Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Dextrose Monohydrate 70% Injection Current Oct. 1, 2026 Other Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Hydromorphone Hydrochloride Injection Current Oct. 1, 2026 Other Analgesia/Addiction
Hydroxocobalamin Injection Current Oct. 1, 2026 Other Other
Methotrexate Sodium Injection Current Oct. 1, 2026 Other Rheumatology, Oncology
Methylphenidate Hydrochloride Tablet, Extended Release Current Oct. 1, 2026 Demand increase for the drug Psychiatry
Midazolam Hydrochloride Injection Current Oct. 1, 2026 Demand increase for the drug Anesthesia, Neurology
Riluzole Oral Suspension Current Oct. 1, 2026 Requirements related to complying with good manufacturing practices Neurology
Sodium Acetate Injection Current Oct. 1, 2026 Other Total Parenteral Nutrition
Sodium Bicarbonate Injection Current Oct. 1, 2026 Other Endocrinology/Metabolism, Gastroenterology, Pediatric
Sterile Water Irrigant Current Oct. 1, 2026 Discontinuation of the manufacture of the drug Gastroenterology, Other, Pediatric
Technetium TC-99M Pyrophosphate Kit Injection Current Oct. 1, 2026 Shortage of an active ingredient Medical Imaging
Cromolyn Sodium Concentrate Current Sept. 30, 2026 Other Pulmonary/Allergy
Bupivacaine Hydrochloride Injection Current Sept. 22, 2026 Demand increase for the drug Anesthesia
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Current Sept. 22, 2026 Other Anesthesia
Dextrose Monohydrate 50% Injection Current Sept. 22, 2026 Other Endocrinology/Metabolism, Gastroenterology, Pediatric
Dobutamine Hydrochloride Injection Current Sept. 22, 2026 Other Cardiovascular, Pediatric, Renal
Dopamine Hydrochloride Injection Current Sept. 22, 2026 Other Cardiovascular
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Current Sept. 22, 2026 Other Anesthesia, Pediatric
Etomidate Injection Current Sept. 22, 2026 Demand increase for the drug Anesthesia
Fentanyl Citrate Injection Current Sept. 22, 2026 Demand increase for the drug Analgesia/Addiction, Pediatric
Furosemide Injection Current Sept. 22, 2026 Other Cardiovascular
Heparin Sodium Injection Current Sept. 22, 2026 Other Hematology
Ketorolac Tromethamine Injection Current Sept. 22, 2026 Other Analgesia/Addiction
Lidocaine Hydrochloride Injection Current Sept. 22, 2026 Other Anesthesia, Pediatric
Liraglutide Injection Current Sept. 22, 2026 Delay in shipping of the drug Endocrinology/Metabolism
Lorazepam Injection Current Sept. 22, 2026 Demand increase for the drug Neurology
Meperidine Hydrochloride Injection Current Sept. 22, 2026 Not stated Analgesia/Addiction
Morphine Sulfate Injection Current Sept. 22, 2026 Discontinuation of the manufacture of the drug Analgesia/Addiction
Promethazine Hydrochloride Injection Current Sept. 22, 2026 Demand increase for the drug Analgesia/Addiction, Gastroenterology, Other, Pulmonary/Allergy
Rocuronium Bromide Injection Current Sept. 22, 2026 Delay in shipping of the drug Anesthesia
Sterile Water Injection Current Sept. 22, 2026 Demand increase for the drug Other
Sufentanil Citrate Injection Current Sept. 22, 2026 Other Analgesia/Addiction, Pediatric
Clindamycin Phosphate Injection Current Sept. 21, 2026 Demand increase for the drug Anti-Infective
Penicillin G Benzathine Injection Current Sept. 21, 2026 Other Anti-Infective
Cefotaxime Sodium Powder, for Solution Current Sept. 18, 2026 Demand increase for the drug Anti-Infective, Pediatric
Dexamethasone Sodium Phosphate Injection Current Sept. 18, 2026 Demand increase for the drug Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology
Furosemide Oral Solution Current Sept. 18, 2026 Shortage of an inactive ingredient component Cardiovascular
Ifosfamide Injection Current Sept. 18, 2026 Demand increase for the drug Oncology, Pediatric
Lisdexamfetamine Dimesylate Tablet, Chewable Current Sept. 18, 2026 Not stated Psychiatry
Propranolol Hydrochloride Injection Current Sept. 18, 2026 Shortage of an active ingredient Cardiovascular
Remifentanil Hydrochloride Injection Current Sept. 18, 2026 Demand increase for the drug Analgesia/Addiction
Rifampin Injection Current Sept. 18, 2026 Discontinuation of the manufacture of the drug Anti-Infective
Valproate Sodium Injection Current Sept. 18, 2026 Not stated Neurology
Metronidazole Injection Current Sept. 17, 2026 Other Anti-Infective
Ropivacaine Hydrochloride Injection Current Sept. 17, 2026 Demand increase for the drug Anesthesia
Conivaptan Hydrochloride Injection Current Sept. 16, 2026 Delay in shipping of the drug Cardiovascular
Desmopressin Acetate Spray Current Sept. 16, 2026 Requirements related to complying with good manufacturing practices Hematology
Streptozocin Powder, For Solution Current Sept. 16, 2026 Other Oncology
Flurazepam Hydrochloride Capsule Current Sept. 15, 2026 Regulatory delay Neurology, Other
Quinapril Hydrochloride Tablet Current Sept. 15, 2026 Requirements related to complying with good manufacturing practices Cardiovascular
Quinapril/Hydrochlorothiazide Tablet Current Sept. 15, 2026 Discontinuation of the manufacture of the drug Cardiovascular
Rifampin Capsule Current Sept. 15, 2026 Discontinuation of the manufacture of the drug Anti-Infective
Triamcinolone Hexacetonide Injection Current Sept. 15, 2026 Not stated Rheumatology
Methylphenidate Film, Extended Release Current Sept. 2, 2026 Not stated Psychiatry
Echothiophate Iodide Ophthalmic Solution Current Sept. 1, 2026 Other Ophthalmology
Pentostatin Injection Current Aug. 27, 2026 Other Oncology
Isocarboxazid Tablet Current Aug. 6, 2026 Other Psychiatry
Bacitracin Ophthalmic Ointment Current June 1, 2026 Discontinuation of the manufacture of the drug Anti-Infective, Ophthalmology

Sources: openFDA recall and shortage records (opens in a new tab)